Marinos Dalakas

TitleProfessor
InstitutionThomas Jefferson University
DepartmentNeurology
Address900 Walnut Street
Philadelphia PA 19107
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Dalmau J, Dalakas MC, Kolson DL, Paul F, Zamvil SS. N2 year in review. Neurol Neuroimmunol Neuroinflamm. 2021 Jan; 8(1). PMID: 33411673.
      Citations:    
    2. Dalakas MC. A HSCT TRIAL IN STIFF PERSON SYNDROME: LIMITED BENEFITS HALT ENROLLMENT BUT SHOULD BE MORE TO COME? Neurology. 2020 Dec 14. PMID: 33318165.
      Citations:    
    3. Vlachoyiannopoulos P, Alexopoulos H, Apostolidi I, Bitzogli K, Barba C, Athanasopoulou E, Dalakas M, Tzioufas A. Anti-SARS-CoV-2 antibody detection in healthcare workers of two tertiary hospitals in Athens, Greece. Clin Immunol. 2020 12; 221:108619. PMID: 33127563.
      Citations:    
    4. Virupakshaiah A, Dalakas MC, Desai N, Mintzer S, Ratliff J. LGI1 encephalitis with squamous lung-cell carcinoma: Resolution after tumor resection. Neurol Neuroimmunol Neuroinflamm. 2021 Jan; 8(1). PMID: 33037051.
      Citations:    
    5. Dalakas MC. Progress in the therapy of myasthenia gravis: getting closer to effective targeted immunotherapies. Curr Opin Neurol. 2020 Oct; 33(5):545-552. PMID: 32833750.
      Citations:    
    6. Dalakas MC, Alexopoulos H, Spaeth PJ. Complement in neurological disorders and emerging complement-targeted therapeutics. Nat Rev Neurol. 2020 Nov; 16(11):601-617. PMID: 33005040.
      Citations:    
    7. Alexopoulos H, Magira E, Bitzogli K, Kafasi N, Vlachoyiannopoulos P, Tzioufas A, Kotanidou A, Dalakas MC. Anti-SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients. Neurol Neuroimmunol Neuroinflamm. 2020 11; 7(6). PMID: 32978291.
      Citations:    
    8. Dalakas MC. Guillain-Barré syndrome: The first documented COVID-19-triggered autoimmune neurologic disease: More to come with myositis in the offing. Neurol Neuroimmunol Neuroinflamm. 2020 09; 7(5). PMID: 32518172.
      Citations:    
    9. Costello F, Dalakas MC. Cranial Neuropathies and COVID-19: Neurotropism and Autoimmunity. Neurology. 2020 Jun 02. PMID: 32487714.
      Citations:    
    10. Gontika M, Skarlis C, Artemiadis A, Pons R, Mastroyianni S, Vartzelis G, Theodorou V, Kilindireas K, Stefanis L, Dalakas M, Chrousos G, Anagnostouli M. HLA-DRB1 allele impact on pediatric multiple sclerosis in a Hellenic cohort. Mult Scler J Exp Transl Clin. 2020 Jan-Mar; 6(1):2055217320908046. PMID: 32133149.
      Citations:    
    11. Dalmau J, Dalakas MC, Kolson DL, Paul F, Zamvil SS. N2 year in review. Neurol Neuroimmunol Neuroinflamm. 2020 Jan; 7(1). PMID: 31831570.
      Citations:    
    12. Dimitriadou MM, Alexopoulos H, Akrivou S, Gola E, Dalakas MC. Anti-Neuronal Antibodies Within the IVIg Preparations: Importance in Clinical Practice. Neurotherapeutics. 2019 Oct 31. PMID: 31673865.
      Citations:    
    13. Dalakas MC. Case 22-2019: A 65-Year-Old Woman with Myopathy. N Engl J Med. 2019 10 24; 381(17):1693. PMID: 31644862.
      Citations:    
    14. Alexopoulos H, Dalakas MC. The immunobiology of autoimmune encephalitides. J Autoimmun. 2019 Nov; 104:102339. PMID: 31611142.
      Citations:    
    15. Kosmidis ML, Pikazis D, Vlachoyiannopoulos P, Tzioufas AG, Dalakas MC. Trial of canakinumab, an IL-1ß receptor antagonist, in patients with inclusion body myositis. Neurol Neuroimmunol Neuroinflamm. 2019 Jul; 6(4):e581. PMID: 31355317.
      Citations:    
    16. Keller CW, Quast I, Dalakas MC, Lünemann JD. IVIG efficacy in CIDP patients is not associated with terminal complement inhibition. J Neuroimmunol. 2019 Feb 10; 330:23-27. PMID: 30772754.
      Citations:    
    17. Dalakas MC. Immunotherapy in myasthenia gravis in the era of biologics. Nat Rev Neurol. 2019 Feb; 15(2):113-124. PMID: 30573759.
      Citations:    
    18. Rakocevic G, Alexopoulos H, Dalakas MC. Quantitative clinical and autoimmune assessments in stiff person syndrome: evidence for a progressive disorder. BMC Neurol. 2019 Jan 03; 19(1):1. PMID: 30606131.
      Citations:    
    19. Dalakas MC. Neurological complications of immune checkpoint inhibitors: what happens when you 'take the brakes off' the immune system. Ther Adv Neurol Disord. 2018; 11:1756286418799864. PMID: 30245744.
      Citations:    
    20. Hughes R, Dalakas MC, Merkies I, Latov N, Léger JM, Nobile-Orazio E, Sobue G, Genge A, Cornblath D, Merschhemke M, Ervin CM, Agoropoulou C, Hartung HP. Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial. Lancet Neurol. 2018 Aug; 17(8):689-698. PMID: 30001923.
      Citations:    
    21. Alexopoulos H, Akrivou S, Mastroyanni S, Antonopoulou M, Dinopoulos A, Giorgi M, Konstantinou K, Kouremenos E, Lariou M, Naoumis D, Pavlidou E, Pavlou E, Voudris K, Vlachoyiannopoulos P, Dalakas MC. Postherpes simplex encephalitis: a case series of viral-triggered autoimmunity, synaptic autoantibodies and response to therapy. Ther Adv Neurol Disord. 2018; 11:1756286418768778. PMID: 29774053.
      Citations:    
    22. Dalakas MC. Myositis: Are autoantibodies pathogenic in necrotizing myopathy? Nat Rev Rheumatol. 2018 May; 14(5):251-252. PMID: 29651118.
      Citations:    
    23. Rakocevic G, Martinez-Outschoorn U, Dalakas MC. Obinutuzumab, a potent anti-B-cell agent, for rituximab-unresponsive IgM anti-MAG neuropathy. Neurol Neuroimmunol Neuroinflamm. 2018 Jul; 5(4):e460. PMID: 29629397.
      Citations:    
    24. Dalakas MC. Advances in the diagnosis, immunopathogenesis and therapies of IgM-anti-MAG antibody-mediated neuropathies. Ther Adv Neurol Disord. 2018; 11:1756285617746640. PMID: 29403542.
      Citations:    
    25. Dalakas MC. Subcutaneous IgG for chronic inflammatory demyelinating polyneuropathy. Lancet Neurol. 2018 Jan; 17(1):20-21. PMID: 29122522.
      Citations:    
    26. Dalakas MC, Rakocevic G, Dambrosia JM, Alexopoulos H, McElroy B. A double-blind, placebo-controlled study of rituximab in patients with stiff person syndrome. Ann Neurol. 2017 Jul 27. PMID: 28749549.
      Citations:    
    27. Dalakas MC. Gene therapy for Duchenne muscular dystrophy: balancing good science, marginal efficacy, high emotions and excessive cost. Ther Adv Neurol Disord. 2017 Aug; 10(8):293-296. PMID: 28781610.
      Citations:    
    28. Dalakas MC. Rituximab in anti-MAG neuropathy: More evidence for efficacy and more predictive factors. J Neurol Sci. 2017 Jun 15; 377:224-226. PMID: 28477700.
      Citations:    
    29. Fouka P, Alexopoulos H, Chatzi I, Dedos SG, Samiotaki M, Panayotou G, Politis P, Tzioufas A, Dalakas MC. Antibodies to inositol 1,4,5-triphosphate receptor 1 in patients with cerebellar disease. Neurol Neuroimmunol Neuroinflamm. 2017 Jan; 4(1):e306. PMID: 27957507.
      Citations:    
    30. Dalakas MC. Treating myasthenia on consensus guide: Helpful and challenging but still unfinished business. Neurology. 2016 Jul 26; 87(4):350-1. PMID: 27358340.
      Citations:    
    31. Dalakas MC. Necrotising autoimmune myopathy (NAM): antibodies seem to be specific markers in aiding diagnosis. J Neurol Neurosurg Psychiatry. 2016 Oct; 87(10):1037. PMID: 27151962.
      Citations:    
    32. Schmidt K, Kleinschnitz K, Rakocevic G, Dalakas MC, Schmidt J. Molecular treatment effects of alemtuzumab in skeletal muscles of patients with IBM. BMC Neurol. 2016; 16(1):48. PMID: 27083892.
      Citations:    
    33. Kampylafka EI, Alexopoulos H, Fouka P, Moutsopoulos HM, Dalakas MC, Tzioufas AG. Epileptic syndrome in systemic lupus erythematosus and neuronal autoantibody associations. Lupus. 2016 Oct; 25(11):1260-5. PMID: 26923281.
      Citations:    
    34. Dalakas MC, Gooch C. Close to the node but far enough: What nodal antibodies tell us about CIDP and its therapies. Neurology. 2016 Mar 1; 86(9):796-7. PMID: 26843563.
      Citations:    
    35. Alexopoulos H, Biba A, Dalakas MC. Anti-B-Cell Therapies in Autoimmune Neurological Diseases: Rationale and Efficacy Trials. Neurotherapeutics. 2016 Jan; 13(1):20-33. PMID: 26566961.
      Citations:    
    36. Kampylafka EI, Alexopoulos H, Dalakas MC, Tzioufas AG. Immunotherapies for Neurological Manifestations in the Context of Systemic Autoimmunity. Neurotherapeutics. 2016 Jan; 13(1):163-78. PMID: 26510559.
      Citations:    
    37. Dalakas MC. Neuro-Immunotherapies: A 30-year Retrospective of an Overwhelming Success and a Brighter Future. Neurotherapeutics. 2016 Jan; 13(1):1-3. PMID: 26684870.
      Citations:    
    38. Magira EE, Alexopoulos H, Charitatos E, Michas D, Dalakas MC. Progressive encephalomyelitis with rigidity and myoclonus (PERM): brucellosis as a possible triggering factor and long-term follow-up therapy with rituximab. Ther Adv Neurol Disord. 2016 Jan; 9(1):69-73. PMID: 26788132.
      Citations:    
    39. Lünemann JD, Quast I, Dalakas MC. Efficacy of Intravenous Immunoglobulin in Neurological Diseases. Neurotherapeutics. 2016 Jan; 13(1):34-46. PMID: 26400261.
      Citations:    
    40. Dalakas MC, Schmidt J. Viruses in IBM: Hit-and-run, hide and persist, or irrelevant? Neurology. 2016 Jan 19; 86(3):204-5. PMID: 26683647.
      Citations:    
    41. Dalakas MC. Future perspectives in target-specific immunotherapies of myasthenia gravis. Ther Adv Neurol Disord. 2015 Nov; 8(6):316-27. PMID: 26600875.
      Citations:    
    42. Alexopoulos H, Kampylafka EI, Fouka P, Tatouli I, Akrivou S, Politis PK, Moutsopoulos HM, Tzioufas AG, Dalakas MC. Anti-aquaporin-4 autoantibodies in systemic lupus erythematosus persist for years and induce astrocytic cytotoxicity but not CNS disease. J Neuroimmunol. 2015 Dec 15; 289:8-11. PMID: 26616866.
      Citations:    
    43. Quast I, Keller CW, Maurer MA, Giddens JP, Tackenberg B, Wang LX, Münz C, Nimmerjahn F, Dalakas MC, Lünemann JD. Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity. J Clin Invest. 2015 Nov 2; 125(11):4160-70. PMID: 26436649.
      Citations:    
    44. Kampylafka EI, Alexopoulos H, El Hamidieh A, Dalakas MC, Andreakos E, Tzioufas AG. Immunization of mice with a peptide derived from the HTLV-1 TAX1BP1 protein induces cross-reactive antibodies against aquaporin 4. Autoimmunity. 2015 Nov; 48(7):453-9. PMID: 26287441.
      Citations:    
    45. Chin RL, Deng C, Bril V, Hartung HP, Merkies IS, Donofrio PD, Van Doorn PA, Dalakas MC, Latov N. Follow-up nerve conduction studies in CIDP after treatment with IGIV-C: Comparison of patients with and without subsequent relapse. Muscle Nerve. 2015 Oct; 52(4):498-502. PMID: 25728021.
      Citations:    
    46. Dalakas MC. Inflammatory Muscle Diseases. N Engl J Med. 2015 Jul 23; 373(4):393-4. PMID: 26200989.
      Citations:    
    47. Chalmoukou K, Alexopoulos H, Akrivou S, Stathopoulos P, Reindl M, Dalakas MC. Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis. Neurol Neuroimmunol Neuroinflamm. 2015 Aug; 2(4):e131. PMID: 26185777.
      Citations:    
    48. Muth IE, Zschüntzsch J, Kleinschnitz K, Wrede A, Gerhardt E, Balcarek P, Schreiber-Katz O, Zierz S, Dalakas MC, Voll RE, Schmidt J. HMGB1 and RAGE in skeletal muscle inflammation: Implications for protein accumulation in inclusion body myositis. Exp Neurol. 2015 Sep; 271:189-97. PMID: 26048613.
      Citations:    
    49. Dalakas MC. Inflammatory muscle diseases. N Engl J Med. 2015 Apr 30; 372(18):1734-47. PMID: 25923553.
      Citations:    
    50. Harris-Love MO, Joe G, Davenport TE, Koziol D, Abbett Rose K, Shrader JA, Vasconcelos OM, McElroy B, Dalakas MC. Reliability of the adult myopathy assessment tool in individuals with myositis. Arthritis Care Res (Hoboken). 2015 Apr; 67(4):563-70. PMID: 25201624.
      Citations:    
    51. Fouka P, Alexopoulos H, Akrivou S, Trohatou O, Politis PK, Dalakas MC. GAD65 epitope mapping and search for novel autoantibodies in GAD-associated neurological disorders. J Neuroimmunol. 2015 Apr 15; 281:73-7. PMID: 25867471.
      Citations:    
    52. Stathopoulos P, Alexopoulos H, Dalakas MC. Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders. Nat Rev Neurol. 2015 Mar; 11(3):143-56. PMID: 25623793.
      Citations:    
    53. Lünemann JD, Nimmerjahn F, Dalakas MC. Intravenous immunoglobulin in neurology--mode of action and clinical efficacy. Nat Rev Neurol. 2015 Feb; 11(2):80-9. PMID: 25561275.
      Citations:    
    54. Davenport TE, Benson K, Baker S, Gracey C, Rakocevic G, McElroy B, Dalakas M, Shrader JA, Harris-Love MO. Lower extremity peak force and gait kinematics in individuals with inclusion body myositis. Arthritis Care Res (Hoboken). 2015 Jan; 67(1):94-101. PMID: 25201017.
      Citations:    
    55. Dalakas MC, Löscher WN. 7(th) International Immunoglobulin Conference: Interlaken Leadership Awards. Clin Exp Immunol. 2014 Dec; 178 Suppl 1:124-6. PMID: 25546789.
      Citations:    
    56. Dalakas MC, Löscher WN. 7(th) International Immunoglobulin Conference: Interlaken Leadership Awards. Clin Exp Immunol. 2014 Dec; 178 Suppl 1:138. PMID: 25546795.
      Citations:    
    57. Alexopoulos H, Dagklis IE, Akrivou S, Bostantjopoulou S, Dalakas MC. Autoimmune encephalitis with GABAB antibodies, thymoma, and GABAB receptor thymic expression. Neurol Neuroimmunol Neuroinflamm. 2014 Dec; 1(4):e39. PMID: 25364773.
      Citations:    
    58. Kosmidis ML, Koutsogeorgopoulou L, Alexopoulos H, Mamali I, Vlachoyiannopoulos PG, Voulgarelis M, Moutsopoulos HM, Tzioufas AG, Dalakas MC. Reduction of Intraepidermal Nerve Fiber Density (IENFD) in the skin biopsies of patients with fibromyalgia: A controlled study. J Neurol Sci. 2014 Dec 15; 347(1-2):143-7. PMID: 25304055.
      Citations:    
    59. Dalakas MC. Pathogenesis of immune-mediated neuropathies. Biochim Biophys Acta. 2015 Apr; 1852(4):658-66. PMID: 24949885.
      Citations:    
    60. Markakis I, Alexopoulos H, Poulopoulou C, Akrivou S, Papathanasiou A, Katsiva V, Lyrakos G, Gekas G, Dalakas MC. Immunotherapy-responsive limbic encephalitis with antibodies to glutamic acid decarboxylase. J Neurol Sci. 2014 Aug 15; 343(1-2):192-4. PMID: 24950904.
      Citations:    
    61. Dalakas MC. Mechanistic Effects of IVIg in Neuroinflammatory Diseases: Conclusions Based on Clinicopathologic Correlations. J Clin Immunol. 2014 Jul; 34 Suppl 1:120-6. PMID: 24722854.
      Citations:    
    62. Davenport TE, Shrader JA, McElroy B, Rakocevic G, Dalakas M, Harris-Love MO. Validity of the single limb heel raise test to predict lower extremity disablement in patients with sporadic inclusion body myositis. Disabil Rehabil. 2014; 36(26):2270-7. PMID: 24678993.
      Citations:    
    63. Dalakas MC. IVIg in the chronic management of myasthenia gravis: Is it enough for your money? J Neurol Sci. 2014 Mar 15; 338(1-2):1-2. PMID: 24411405.
      Citations:    
    64. Harris-Love MO, Shrader JA, Davenport TE, Joe G, Rakocevic G, McElroy B, Dalakas M. Are repeated single-limb heel raises and manual muscle testing associated with peak plantar-flexor force in people with inclusion body myositis? Phys Ther. 2014 Apr; 94(4):543-52. PMID: 24309617.
      Citations:    
    65. Alexopoulos H, Dalakas MC. Immunology of stiff person syndrome and other GAD-associated neurological disorders. Expert Rev Clin Immunol. 2013 Nov; 9(11):1043-53. PMID: 24168411.
      Citations:    
    66. Alexopoulos H, Akrivou S, Dalakas MC. Glycine receptor antibodies in stiff-person syndrome and other GAD-positive CNS disorders. Neurology. 2013 Nov 26; 81(22):1962-4. PMID: 24174585.
      Citations:    
    67. Schmidt J, Dalakas MC. Inclusion body myositis: from immunopathology and degenerative mechanisms to treatment perspectives. Expert Rev Clin Immunol. 2013 Nov; 9(11):1125-33. PMID: 24138579.
      Citations:    
    68. Kosmidis ML, Alexopoulos H, Tzioufas AG, Dalakas MC. The effect of anakinra, an IL1 receptor antagonist, in patients with sporadic inclusion body myositis (sIBM): A small pilot study. J Neurol Sci. 2013 Nov 15; 334(1-2):123-5. PMID: 23998706.
      Citations:    
    69. Alexopoulos H, Kampylafka EI, Chatzi I, Travasarou M, Karageorgiou KE, Dalakas MC, Tzioufas AG. Reactivity to AQP4 epitopes in relapsing-remitting multiple sclerosis. J Neuroimmunol. 2013 Jul 15; 260(1-2):117-20. PMID: 23673145.
      Citations:    
    70. Dalakas MC. Pathophysiology of autoimmune polyneuropathies. Presse Med. 2013 Jun; 42(6 Pt 2):e181-92. PMID: 23642299.
      Citations:    
    71. Dalakas MC. Novel future therapeutic options in Myasthenia Gravis. Autoimmun Rev. 2013 Jul; 12(9):936-41. PMID: 23537505.
      Citations:    
    72. Toro C, Olivé M, Dalakas MC, Sivakumar K, Bilbao JM, Tyndel F, Vidal N, Farrero E, Sambuughin N, Goldfarb LG. Exome sequencing identifies titin mutations causing hereditary myopathy with early respiratory failure (HMERF) in families of diverse ethnic origins. BMC Neurol. 2013; 13:29. PMID: 23514108.
      Citations:    
    73. Dalakas MC. Progress and stiff challenges in understanding the role of GAD-antibodies in stiff-person syndrome. Exp Neurol. 2013 Sep; 247:303-7. PMID: 23485793.
      Citations:    
    74. Kampylafka EI, Alexopoulos H, Kosmidis ML, Panagiotakos DB, Vlachoyiannopoulos PG, Dalakas MC, Moutsopoulos HM, Tzioufas AG. Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patients. PLoS One. 2013; 8(2):e55843. PMID: 23424638.
      Citations:    
    75. Voss JG, Dobra A, Morse C, Kovacs JA, Danner RL, Munson PJ, Logan C, Rangel Z, Adelsberger JW, McLaughlin M, Adams LD, Raju R, Dalakas MC. Fatigue-Related Gene Networks Identified in CD14+ Cells Isolated From HIV-Infected Patients--Part I: Research Findings. Biol Res Nurs. 2013 Apr; 15(2):137-51. PMID: 23324479.
      Citations:    
    76. Dalakas MC. Biologics and other novel approaches as new therapeutic options in myasthenia gravis: a view to the future. Ann N Y Acad Sci. 2012 Dec; 1274(1):1-8. PMID: 23252891.
      Citations:    
    77. Zschüntzsch J, Voss J, Creus K, Sehmisch S, Raju R, Dalakas MC, Schmidt J. Provision of an explanation for the inefficacy of immunotherapy in sporadic inclusion body myositis: Quantitative assessment of inflammation and ß-amyloid in the muscle. Arthritis Rheum. 2012 Dec; 64(12):4094-103. PMID: 22941914.
      Citations:    
    78. Vanhoutte EK, Latov N, Deng C, Hanna K, Hughes RA, Bril V, Dalakas MC, Donofrio P, van Doorn PA, Hartung HP, Merkies IS. Vigorimeter grip strength in CIDP: a responsive tool that rapidly measures the effect of IVIG--the ICE study. Eur J Neurol. 2013 May; 20(5):748-55. PMID: 22891893.
      Citations:    
    79. Scott AP, Laing NG, Mastaglia F, Dalakas M, Needham M, Allcock RJ. Investigation of NOTCH4 coding region polymorphisms in sporadic inclusion body myositis. J Neuroimmunol. 2012 Sep 15; 250(1-2):66-70. PMID: 22732452.
      Citations:    
    80. Dalakas MC. Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies. J Peripher Nerv Syst. 2012 May; 17 Suppl 2:34-9. PMID: 22548621.
      Citations:    
    81. Morse CG, Voss JG, Rakocevic G, McLaughlin M, Vinton CL, Huber C, Hu X, Yang J, Huang da W, Logun C, Danner RL, Rangel ZG, Munson PJ, Orenstein JM, Rushing EJ, Lempicki RA, Dalakas MC, Kovacs JA. HIV infection and antiretroviral therapy have divergent effects on mitochondria in adipose tissue. J Infect Dis. 2012 Jun 15; 205(12):1778-87. PMID: 22476717.
      Citations:    
    82. Schmidt J, Barthel K, Zschüntzsch J, Muth IE, Swindle EJ, Hombach A, Sehmisch S, Wrede A, Lühder F, Gold R, Dalakas MC. Nitric oxide stress in sporadic inclusion body myositis muscle fibres: inhibition of inducible nitric oxide synthase prevents interleukin-1ß-induced accumulation of ß-amyloid and cell death. Brain. 2012 Apr; 135(Pt 4):1102-14. PMID: 22436237.
      Citations:    
    83. Maurer MA, Rakocevic G, Leung CS, Quast I, Lukacišin M, Goebels N, Münz C, Wardemann H, Dalakas M, Lünemann JD. Rituximab induces sustained reduction of pathogenic B cells in patients with peripheral nervous system autoimmunity. J Clin Invest. 2012 Apr 2; 122(4):1393-402. PMID: 22426210.
      Citations:    
    84. Pavlakis PP, Alexopoulos H, Kosmidis ML, Mamali I, Moutsopoulos HM, Tzioufas AG, Dalakas MC. Peripheral neuropathies in Sjögren's syndrome: a critical update on clinical features and pathogenetic mechanisms. J Autoimmun. 2012 Aug; 39(1-2):27-33. PMID: 22318209.
      Citations:    
    85. Voss JG, Dobra A, Morse C, Kovacs JA, Raju R, Danner RL, Munson PJ, Logan C, Rangel Z, Adelsberger JW, McLaughlin M, Adams LD, Dalakas MC. Fatigue-Related Gene Networks Identified in CD14+ Cells Isolated From HIV-Infected Patients--Part II: Statistical Analysis. Biol Res Nurs. 2013 Apr; 15(2):152-9. PMID: 22084402.
      Citations:    
    86. Dalakas MC. Inflammatory myopathies: management of steroid resistance. Curr Opin Neurol. 2011 Oct; 24(5):457-62. PMID: 21799409.
      Citations:    
    87. Dalakas MC. Advances in the diagnosis, pathogenesis and treatment of CIDP. Nat Rev Neurol. 2011 Sep; 7(9):507-17. PMID: 21844897.
      Citations:    
    88. Deng C, Hanna K, Bril V, Dalakas MC, Donofrio P, van Doorn PA, Hartung HP, Merkies IS. Challenges of clinical trial design when there is lack of clinical equipoise: use of a response-conditional crossover design. J Neurol. 2012 Feb; 259(2):348-52. PMID: 21822934.
      Citations:    
    89. Dalakas MC. Immunotherapy of inflammatory myopathies: practical approach and future prospects. Curr Treat Options Neurol. 2011 Jun; 13(3):311-23. PMID: 21365201.
      Citations:    
    90. Latov N, Dalakas M, Vallat JM, Donofrio P, Hartung HP, Toyka KV. Biomarkers in the diagnosis and therapy of CIDP: Proceedings of the Biomarkers Faculty Meeting; June 8-9, 2010, Athens, Greece. J Peripher Nerv Syst. 2011 Jun; 16 Suppl 1:1-2. PMID: 21696489.
      Citations:    
    91. Dalakas MC. Potential biomarkers for monitoring therapeutic response in patients with CIDP. J Peripher Nerv Syst. 2011 Jun; 16 Suppl 1:63-7. PMID: 21696503.
      Citations:    
    92. Dalakas MC. Pathogenesis and therapies of immune-mediated myopathies. Autoimmun Rev. 2012 Jan; 11(3):203-6. PMID: 21619945.
      Citations:    
    93. Scott AP, Laing NG, Mastaglia F, Needham M, Walter MC, Dalakas MC, Allcock RJ. Recombination mapping of the susceptibility region for sporadic inclusion body myositis within the major histocompatibility complex. J Neuroimmunol. 2011 Jun; 235(1-2):77-83. PMID: 21543121.
      Citations:    
    94. Dalakas MC. Review: An update on inflammatory and autoimmune myopathies. Neuropathol Appl Neurobiol. 2011 Apr; 37(3):226-42. PMID: 21155862.
      Citations:    
    95. Dalakas MC. Pathophysiology of inflammatory and autoimmune myopathies. Presse Med. 2011 Apr; 40(4 Pt 2):e237-47. PMID: 21411269.
      Citations:    
    96. Alexopoulos H, Kosmidis ML, Dalmau J, Dalakas MC. Paraneoplastic anti-NMDAR encephalitis: long term follow-up reveals persistent serum antibodies. J Neurol. 2011 Aug; 258(8):1568-70. PMID: 21384161.
      Citations:    
    97. Kampylafka EI, Routsias JG, Alexopoulos H, Dalakas MC, Moutsopoulos HM, Tzioufas AG. Fine specificity of antibodies against AQP4: epitope mapping reveals intracellular epitopes. J Autoimmun. 2011 May; 36(3-4):221-7. PMID: 21333492.
      Citations:    
    98. Pavlakis PP, Alexopoulos H, Kosmidis ML, Stamboulis E, Routsias JG, Tzartos SJ, Tzioufas AG, Moutsopoulos HM, Dalakas MC. Peripheral neuropathies in Sjogren syndrome: a new reappraisal. J Neurol Neurosurg Psychiatry. 2011 Jul; 82(7):798-802. PMID: 21172862.
      Citations:    
    99. Bril V, Banach M, Dalakas MC, Deng C, Donofrio P, Hanna K, Hartung HP, Hughes RA, Katzberg H, Latov N, Merkies IS, Van Doorn PA. Electrophysiologic correlations with clinical outcomes in CIDP. Muscle Nerve. 2010 Oct; 42(4):492-7. PMID: 20665514.
      Citations:    
    100. Donofrio PD, Bril V, Dalakas MC, Deng C, Hanna K, Hartung HP, Hughes R, Latov N, Merkies I, van Doorn P. Safety and tolerability of immune globulin intravenous in chronic inflammatory demyelinating polyradiculoneuropathy. Arch Neurol. 2010 Sep; 67(9):1082-8. PMID: 20837852.
      Citations:    
    101. Merkies IS, Hughes RA, Donofrio P, Bril V, Dalakas MC, Hanna K, Hartung HP, Latov N, van Doorn PA, Deng C. Understanding the consequences of chronic inflammatory demyelinating polyradiculoneuropathy from impairments to activity and participation restrictions and reduced quality of life: the ICE study. J Peripher Nerv Syst. 2010 Sep; 15(3):208-15. PMID: 21040143.
      Citations:    
    102. Alexopoulos H, Dalakas MC. A critical update on the immunopathogenesis of Stiff Person Syndrome. Eur J Clin Invest. 2010 Nov; 40(11):1018-25. PMID: 20636380.
      Citations:    
    103. Latov N, Deng C, Dalakas MC, Bril V, Donofrio P, Hanna K, Hartung HP, Hughes RA, Merkies IS, van Doorn PA. Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy. Arch Neurol. 2010 Jul; 67(7):802-7. PMID: 20457948.
      Citations:    
    104. Dalakas MC. Inflammatory muscle diseases: a critical review on pathogenesis and therapies. Curr Opin Pharmacol. 2010 Jun; 10(3):346-52. PMID: 20409756.
      Citations:    
    105. Schmidt J, Dalakas MC. Pathomechanisms of inflammatory myopathies: recent advances and implications for diagnosis and therapies. Expert Opin Med Diagn. 2010 May; 4(3):241-50. PMID: 23488533.
      Citations:    
    106. Dalakas MC. Pathogenesis and Treatment of Anti-MAG Neuropathy. Curr Treat Options Neurol. 2010 Mar; 12(2):71-83. PMID: 20842571.
      Citations:    
    107. Kosmidis ML, Dalakas MC. Practical considerations on the use of rituximab in autoimmune neurological disorders. Ther Adv Neurol Disord. 2010 Mar; 3(2):93-105. PMID: 21179602.
      Citations:    
    108. Dalakas MC. Immunotherapy of myositis: issues, concerns and future prospects. Nat Rev Rheumatol. 2010 Mar; 6(3):129-37. PMID: 20125096.
      Citations:    
    109. Hughes RA, Dalakas MC, Cornblath DR, Latov N, Weksler ME, Relkin N. Clinical applications of intravenous immunoglobulins in neurology. Clin Exp Immunol. 2009 Dec; 158 Suppl 1:34-42. PMID: 19883422.
      Citations:    
    110. Goldfarb LG, Dalakas MC. Tragedy in a heartbeat: malfunctioning desmin causes skeletal and cardiac muscle disease. J Clin Invest. 2009 Jul; 119(7):1806-13. PMID: 19587455.
      Citations:    
    111. Muth IE, Barthel K, Bähr M, Dalakas MC, Schmidt J. Proinflammatory cell stress in sporadic inclusion body myositis muscle: overexpression of alphaB-crystallin is associated with amyloid precursor protein and accumulation of beta-amyloid. J Neurol Neurosurg Psychiatry. 2009 Dec; 80(12):1344-9. PMID: 19470495.
      Citations:    
    112. Dalakas MC, Rakocevic G, Schmidt J, Salajegheh M, McElroy B, Harris-Love MO, Shrader JA, Levy EW, Dambrosia J, Kampen RL, Bruno DA, Kirk AD. Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis. Brain. 2009 Jun; 132(Pt 6):1536-44. PMID: 19454532.
      Citations:    
    113. Merkies IS, Bril V, Dalakas MC, Deng C, Donofrio P, Hanna K, Hartung HP, Hughes RA, Latov N, van Doorn PA. Health-related quality-of-life improvements in CIDP with immune globulin IV 10%: the ICE Study. Neurology. 2009 Apr 14; 72(15):1337-44. PMID: 19365055.
      Citations:    
    114. Bril V, Katzberg H, Donofrio P, Banach M, Dalakas MC, Deng C, Hanna K, Hartung HP, Hughes RA, Latov N, Merkies IS, van Doorn PA. Electrophysiology in chronic inflammatory demyelinating polyneuropathy with IGIV. Muscle Nerve. 2009 Apr; 39(4):448-55. PMID: 19260050.
      Citations:    
    115. Dalakas MC, Rakocevic G, Salajegheh M, Dambrosia JM, Hahn AF, Raju R, McElroy B. Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy. Ann Neurol. 2009 Mar; 65(3):286-93. PMID: 19334068.
      Citations:    
    116. Dalakas MC. Stiff person syndrome: advances in pathogenesis and therapeutic interventions. Curr Treat Options Neurol. 2009 Mar; 11(2):102-10. PMID: 19210912.
      Citations:    
    117. Menge T, Büdingen HC, Dalakas MC, Kieseier BC, Hartung HP. [Targeting B cells in multiple sclerosis. Current concepts and strategies]. Nervenarzt. 2009 Feb; 80(2):190-8. PMID: 19189075.
      Citations:    
    118. Shatunov A, Olivé M, Odgerel Z, Stadelmann-Nessler C, Irlbacher K, van Landeghem F, Bayarsaikhan M, Lee HS, Goudeau B, Chinnery PF, Straub V, Hilton-Jones D, Damian MS, Kaminska A, Vicart P, Bushby K, Dalakas MC, Sambuughin N, Ferrer I, Goebel HH, Goldfarb LG. In-frame deletion in the seventh immunoglobulin-like repeat of filamin C in a family with myofibrillar myopathy. Eur J Hum Genet. 2009 May; 17(5):656-63. PMID: 19050726.
      Citations:    
    119. Dalakas MC. Therapeutic advances and future prospects in immune-mediated inflammatory myopathies. Ther Adv Neurol Disord. 2008 Nov; 1(3):157-66. PMID: 21180574.
      Citations:    
    120. Dalakas MC. B cells as therapeutic targets in autoimmune neurological disorders. Nat Clin Pract Neurol. 2008 Oct; 4(10):557-67. PMID: 18813230.
      Citations:    
    121. Dalakas MC, Smith SA. A "nema" of hope in the treatment of late-onset nemaline myopathy. Neurology. 2008 Aug 12; 71(7):472-3. PMID: 18695157.
      Citations:    
    122. Dalakas M. IVIg in other autoimmune neurological disorders: current status and future prospects. J Neurol. 2008 Jul; 255 Suppl 3:12-6. PMID: 18685921.
      Citations:    
    123. Dalakas MC. Interplay between inflammation and degeneration: using inclusion body myositis to study "neuroinflammation". Ann Neurol. 2008 Jul; 64(1):1-3. PMID: 18626972.
      Citations:    
    124. Dalakas MC. Invited article: inhibition of B cell functions: implications for neurology. Neurology. 2008 Jun 3; 70(23):2252-60. PMID: 18519875.
      Citations:    
    125. Schmidt J, Barthel K, Wrede A, Salajegheh M, Bähr M, Dalakas MC. Interrelation of inflammation and APP in sIBM: IL-1 beta induces accumulation of beta-amyloid in skeletal muscle. Brain. 2008 May; 131(Pt 5):1228-40. PMID: 18420712.
      Citations:    
    126. Voss JG, Raju R, Logun C, Danner RL, Munson PJ, Rangel Z, Dalakas MC. A focused microarray to study human mitochondrial and nuclear gene expression. Biol Res Nurs. 2008 Apr; 9(4):272-9. PMID: 18398222.
      Citations:    
    127. Hughes RA, Donofrio P, Bril V, Dalakas MC, Deng C, Hanna K, Hartung HP, Latov N, Merkies IS, van Doorn PA. Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial. Lancet Neurol. 2008 Feb; 7(2):136-44. PMID: 18178525.
      Citations:    
    128. Dalakas MC. Advances in the pathogenesis and treatment of patients with stiff person syndrome. Curr Neurol Neurosci Rep. 2008 Jan; 8(1):48-55. PMID: 18367039.
      Citations:    
    129. Burbelo PD, Groot S, Dalakas MC, Iadarola MJ. High definition profiling of autoantibodies to glutamic acid decarboxylases GAD65/GAD67 in stiff-person syndrome. Biochem Biophys Res Commun. 2008 Feb 1; 366(1):1-7. PMID: 18047830.
      Citations:    
    130. Ilyas AA, Gu Y, Dalakas MC, Quarles RH, Bhatt S. Induction of experimental ataxic sensory neuronopathy in cats by immunization with purified SGPG. J Neuroimmunol. 2008 Jan; 193(1-2):87-93. PMID: 18037501.
      Citations:    
    131. Salajegheh M, Rakocevic G, Raju R, Shatunov A, Goldfarb LG, Dalakas MC. T cell receptor profiling in muscle and blood lymphocytes in sporadic inclusion body myositis. Neurology. 2007 Oct 23; 69(17):1672-9. PMID: 17954782.
      Citations:    
    132. Dalakas MC. Advances in the immunobiology and treatment of inflammatory myopathies. Curr Rheumatol Rep. 2007 Aug; 9(4):291-7. PMID: 17688838.
      Citations:    
    133. Lünemann JD, Schmidt J, Dalakas MC, Münz C. Macroautophagy as a pathomechanism in sporadic inclusion body myositis. Autophagy. 2007 Jul-Aug; 3(4):384-6. PMID: 17438365.
      Citations:    
    134. Salajegheh M, Raju R, Schmidt J, Dalakas MC. Upregulation of thrombospondin-1(TSP-1) and its binding partners, CD36 and CD47, in sporadic inclusion body myositis. J Neuroimmunol. 2007 Jul; 187(1-2):166-74. PMID: 17572512.
      Citations:    
    135. Vasconcelos OM, Prokhorenko OA, Salajegheh MK, Kelley KF, Livornese K, Olsen CH, Vo AH, Dalakas MC, Halstead LS, Jabbari B, Campbell WW. Modafinil for treatment of fatigue in post-polio syndrome: a randomized controlled trial. Neurology. 2007 May 15; 68(20):1680-6. PMID: 17502549.
      Citations:    
    136. Lünemann JD, Schmidt J, Schmid D, Barthel K, Wrede A, Dalakas MC, Münz C. Beta-amyloid is a substrate of autophagy in sporadic inclusion body myositis. Ann Neurol. 2007 May; 61(5):476-83. PMID: 17469125.
      Citations:    
    137. Dalakas MC, Rakocevic G, Shatunov A, Goldfarb L, Raju R, Salajegheh M. Inclusion body myositis with human immunodeficiency virus infection: four cases with clonal expansion of viral-specific T cells. Ann Neurol. 2007 May; 61(5):466-75. PMID: 17366634.
      Citations:    
    138. Raju R, Dalakas MC. Absence of upregulated genes associated with protein accumulations in desmin myopathy. Muscle Nerve. 2007 Mar; 35(3):386-8. PMID: 17068785.
      Citations:    
    139. Lupu VD, Mora CA, Dambrosia J, Meer J, Dalakas M, Floeter MK. Terminal latency index in neuropathy with antibodies against myelin-associated glycoproteins. Muscle Nerve. 2007 Feb; 35(2):196-202. PMID: 17068765.
      Citations:    
    140. Mavragani CP, Patronas N, Dalakas M, Moutsopoulos HM. Ill-defined neurological syndromes with autoimmune background: a diagnostic challenge. J Rheumatol. 2007 Feb; 34(2):341-5. PMID: 17304657.
      Citations:    
    141. Sparks S, Rakocevic G, Joe G, Manoli I, Shrader J, Harris-Love M, Sonies B, Ciccone C, Dorward H, Krasnewich D, Huizing M, Dalakas MC, Gahl WA. Intravenous immune globulin in hereditary inclusion body myopathy: a pilot study. BMC Neurol. 2007; 7:3. PMID: 17261181.
      Citations:    
    142. Gold R, Stangel M, Dalakas MC. Drug Insight: the use of intravenous immunoglobulin in neurology--therapeutic considerations and practical issues. Nat Clin Pract Neurol. 2007 Jan; 3(1):36-44. PMID: 17205073.
      Citations:    
    143. Dalakas MC. Autoimmune inflammatory myopathies. Handb Clin Neurol. 2007; 86:273-301. PMID: 18809006.
      Citations:    
    144. Rakocevic G, Raju R, Semino-Mora C, Dalakas MC. Stiff person syndrome with cerebellar disease and high-titer anti-GAD antibodies. Neurology. 2006 Sep 26; 67(6):1068-70. PMID: 17000981.
      Citations:    
    145. Salajegheh M, Bryan WW, Dalakas MC. The challenge of diagnosing ALS in patients with prior poliomyelitis. Neurology. 2006 Sep 26; 67(6):1078-9. PMID: 17000983.
      Citations:    
    146. Raju R, Rakocevic G, Chen Z, Hoehn G, Semino-Mora C, Shi W, Olsen R, Dalakas MC. Autoimmunity to GABAA-receptor-associated protein in stiff-person syndrome. Brain. 2006 Dec; 129(Pt 12):3270-6. PMID: 16984900.
      Citations:    
    147. Dalakas MC. Role of IVIg in autoimmune, neuroinflammatory and neurodegenerative disorders of the central nervous system: present and future prospects. J Neurol. 2006 Sep; 253 Suppl 5:V25-32. PMID: 16998751.
      Citations:    
    148. Vasconcelos OM, Prokhorenko OA, Kelley KF, Vo AH, Olsen CH, Dalakas MC, Halstead LS, Jabbari B, Campbell WW. A comparison of fatigue scales in postpoliomyelitis syndrome. Arch Phys Med Rehabil. 2006 Sep; 87(9):1213-7. PMID: 16935057.
      Citations:    
    149. Goudeau B, Rodrigues-Lima F, Fischer D, Casteras-Simon M, Sambuughin N, de Visser M, Laforet P, Ferrer X, Chapon F, Sjöberg G, Kostareva A, Sejersen T, Dalakas MC, Goldfarb LG, Vicart P. Variable pathogenic potentials of mutations located in the desmin alpha-helical domain. Hum Mutat. 2006 Sep; 27(9):906-13. PMID: 16865695.
      Citations:    
    150. Dalakas MC. Sporadic inclusion body myositis--diagnosis, pathogenesis and therapeutic strategies. Nat Clin Pract Neurol. 2006 Aug; 2(8):437-47. PMID: 16932602.
      Citations:    
    151. Briani C, Doria A, Sarzi-Puttini P, Dalakas MC. Update on idiopathic inflammatory myopathies. Autoimmunity. 2006 May; 39(3):161-70. PMID: 16769649.
      Citations:    
    152. Dalakas MC. B cells in the pathophysiology of autoimmune neurological disorders: a credible therapeutic target. Pharmacol Ther. 2006 Oct; 112(1):57-70. PMID: 16644016.
      Citations:    
    153. Dalakas MC. Mechanisms of disease: signaling pathways and immunobiology of inflammatory myopathies. Nat Clin Pract Rheumatol. 2006 Apr; 2(4):219-27. PMID: 16932688.
      Citations:    
    154. Dalakas MC. Therapeutic targets in patients with inflammatory myopathies: present approaches and a look to the future. Neuromuscul Disord. 2006 Apr; 16(4):223-36. PMID: 16542836.
      Citations:    
    155. Latov N, Gorson KC, Brannagan TH, Freeman RL, Apostolski S, Berger AR, Bradley WG, Briani C, Bril V, Busis NA, Cros DP, Dalakas MC, Donofrio PD, Dyck PJ, England JD, Fisher MA, Herrmann DN, Menkes DL, Sahenk Z, Sander HW, Triggs WJ, Vallat JM. Diagnosis and Treatment of Chronic Immune-mediated Neuropathies. J Clin Neuromuscul Dis. 2006 Mar; 7(3):141-57. PMID: 19078800.
      Citations:    
    156. Dalakas MC. Inflammatory, immune, and viral aspects of inclusion-body myositis. Neurology. 2006 Jan 24; 66(2 Suppl 1):S33-8. PMID: 16432143.
      Citations:    
    157. Dalakas MC. The role of high-dose immune globulin intravenous in the treatment of dermatomyositis. Int Immunopharmacol. 2006 Apr; 6(4):550-6. PMID: 16504918.
      Citations:    
    158. Dalakas MC. Intravenous immunoglobulin in patients with anti-GAD antibody-associated neurological diseases and patients with inflammatory myopathies: effects on clinicopathological features and immunoregulatory genes. Clin Rev Allergy Immunol. 2005 Dec; 29(3):255-69. PMID: 16391401.
      Citations:    
    159. Raju R, Foote J, Banga JP, Hall TR, Padoa CJ, Dalakas MC, Ortqvist E, Hampe CS. Analysis of GAD65 autoantibodies in Stiff-Person syndrome patients. J Immunol. 2005 Dec 1; 175(11):7755-62. PMID: 16301686.
      Citations:    
    160. Schreiner B, Voss J, Wischhusen J, Dombrowski Y, Steinle A, Lochmüller H, Dalakas M, Melms A, Wiendl H. Expression of toll-like receptors by human muscle cells in vitro and in vivo: TLR3 is highly expressed in inflammatory and HIV myopathies, mediates IL-8 release and up-regulation of NKG2D-ligands. FASEB J. 2006 Jan; 20(1):118-20. PMID: 16293707.
      Citations:    
    161. Gottlieb E, Ciccone C, Darvish D, Naiem-Cohen S, Dalakas MC, Savelkoul PJ, Krasnewich DM, Gahl WA, Huizing M. Single nucleotide polymorphisms in the dystroglycan gene do not correlate with disease severity in hereditary inclusion body myopathy. Mol Genet Metab. 2005 Sep-Oct; 86(1-2):244-9. PMID: 16112887.
      Citations:    
    162. Sivakumar K, Kyriakides T, Puls I, Nicholson GA, Funalot B, Antonellis A, Sambuughin N, Christodoulou K, Beggs JL, Zamba-Papanicolaou E, Ionasescu V, Dalakas MC, Green ED, Fischbeck KH, Goldfarb LG. Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations. Brain. 2005 Oct; 128(Pt 10):2304-14. PMID: 16014653.
      Citations:    
    163. Sparks SE, Ciccone C, Lalor M, Orvisky E, Klootwijk R, Savelkoul PJ, Dalakas MC, Krasnewich DM, Gahl WA, Huizing M. Use of a cell-free system to determine UDP-N-acetylglucosamine 2-epimerase and N-acetylmannosamine kinase activities in human hereditary inclusion body myopathy. Glycobiology. 2005 Nov; 15(11):1102-10. PMID: 15987957.
      Citations:    
    164. Ameli R, Snow J, Rakocevic G, Dalakas MC. A neuropsychological assessment of phobias in patients with stiff person syndrome. Neurology. 2005 Jun 14; 64(11):1961-3. PMID: 15955955.
      Citations:    
    165. Levy LM, Levy-Reis I, Fujii M, Dalakas MC. Brain gamma-aminobutyric acid changes in stiff-person syndrome. Arch Neurol. 2005 Jun; 62(6):970-4. PMID: 15956168.
      Citations:    
    166. Dalakas MC. The role of IVIg in the treatment of patients with stiff person syndrome and other neurological diseases associated with anti-GAD antibodies. J Neurol. 2005 May; 252 Suppl 1:I19-25. PMID: 15959668.
      Citations:    
    167. Dalakas MC. Autoimmune muscular pathologies. Neurol Sci. 2005 May; 26 Suppl 1:S7-8. PMID: 15883700.
      Citations:    
    168. Raju R, Dalakas MC. Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes. Brain. 2005 Aug; 128(Pt 8):1887-96. PMID: 15857930.
      Citations:    
    169. Renaud S, Hays AP, Brannagan TH, Sander HW, Edgar M, Weimer LH, Olarte MR, Dalakas MC, Xiang Z, Danon MJ, Latov N. Gene expression profiling in chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol. 2005 Feb; 159(1-2):203-14. PMID: 15652421.
      Citations:    
    170. Dalakas MC. Inhibiting leukocyte recruitment to the brain by IVIg: is it relevant to the treatment of demyelinating CNS disorders? Brain. 2004 Dec; 127(Pt 12):2569-71. PMID: 15561895.
      Citations:    
    171. Miller TM, Dias da Silva MR, Miller HA, Kwiecinski H, Mendell JR, Tawil R, McManis P, Griggs RC, Angelini C, Servidei S, Petajan J, Dalakas MC, Ranum LP, Fu YH, Ptácek LJ. Correlating phenotype and genotype in the periodic paralyses. Neurology. 2004 Nov 9; 63(9):1647-55. PMID: 15534250.
      Citations:    
    172. Dalakas MC. Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis. Curr Opin Neurol. 2004 Oct; 17(5):561-7. PMID: 15367860.
      Citations:    
    173. Dalakas MC. Update on the molecular pathogenesis of inflammatory myopathies. Autoimmun Rev. 2004 Jun; 3 Suppl 1:S37-9. PMID: 15309788.
      Citations:    
    174. Dalakas MC. The future prospects in the classification, diagnosis and therapies of inflammatory myopathies: a view to the future from the "bench-to-bedside". J Neurol. 2004 Jun; 251(6):651-7. PMID: 15311338.
      Citations:    
    175. Dalakas MC. The molecular pathophysiology in inflammatory myopathies. Rev Med Interne. 2004 Jun; 25 Suppl 1:S14-6. PMID: 15165685.
      Citations:    
    176. Dalakas MC. From canine to man: on antibodies, macrophages, and dendritic cells in inflammatory myopathies. Muscle Nerve. 2004 Jun; 29(6):753-5. PMID: 15170607.
      Citations:    
    177. Rakocevic G, Raju R, Dalakas MC. Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity. Arch Neurol. 2004 Jun; 61(6):902-4. PMID: 15210528.
      Citations:    
    178. Dalakas MC. The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile. Pharmacol Ther. 2004 Jun; 102(3):177-93. PMID: 15246245.
      Citations:    
    179. Dalakas MC. Intravenous immunoglobulin in autoimmune neuromuscular diseases. JAMA. 2004 May 19; 291(19):2367-75. PMID: 15150209.
      Citations:    
    180. Schmidt J, Rakocevic G, Raju R, Dalakas MC. Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity. Brain. 2004 May; 127(Pt 5):1182-90. PMID: 15047591.
      Citations:    
    181. Huizing M, Rakocevic G, Sparks SE, Mamali I, Shatunov A, Goldfarb L, Krasnewich D, Gahl WA, Dalakas MC. Hypoglycosylation of alpha-dystroglycan in patients with hereditary IBM due to GNE mutations. Mol Genet Metab. 2004 Mar; 81(3):196-202. PMID: 14972325.
      Citations:    
    182. Dagvadorj A, Olivé M, Urtizberea JA, Halle M, Shatunov A, Bönnemann C, Park KY, Goebel HH, Ferrer I, Vicart P, Dalakas MC, Goldfarb LG. A series of West European patients with severe cardiac and skeletal myopathy associated with a de novo R406W mutation in desmin. J Neurol. 2004 Feb; 251(2):143-9. PMID: 14991347.
      Citations:    
    183. Goldfarb LG, Vicart P, Goebel HH, Dalakas MC. Desmin myopathy. Brain. 2004 Apr; 127(Pt 4):723-34. PMID: 14724127.
      Citations:    
    184. Dalakas MC. Molecular pathogenesis of inflammatory myopathies and future therapeutic strategies. Suppl Clin Neurophysiol. 2004; 57:288-303. PMID: 16106627.
      Citations:    
    185. Berger AR, Bradley WG, Brannagan TH, Busis NA, Cros DP, Dalakas MC, Danon MJ, Donofrio P, Engel WK, England JD, Feldman EL, Freeman RL, Kinsella LJ, Lacomis D, Latov N, Menkes DL, Sander HW, Thomas FP, Triggs WJ, Windebank AJ, Wolfe GI. Guidelines for the diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy. J Peripher Nerv Syst. 2003 Dec; 8(4):282-4. PMID: 14641652.
      Citations:    
    186. Kaminska A, Strelkov SV, Goudeau B, Olivé M, Dagvadorj A, Fidzianska A, Simon-Casteras M, Shatunov A, Dalakas MC, Ferrer I, Kwiecinski H, Vicart P, Goldfarb LG. Small deletions disturb desmin architecture leading to breakdown of muscle cells and development of skeletal or cardioskeletal myopathy. Hum Genet. 2004 Feb; 114(3):306-13. PMID: 14648196.
      Citations:    
    187. McCrone P, Chisholm D, Knapp M, Hughes R, Comi G, Dalakas MC, Illa I, Kilindireas C, Nobile-Orazio E, Swan A, Van den Bergh P, Willison HJ. Cost-utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol. 2003 Nov; 10(6):687-94. PMID: 14641514.
      Citations:    
    188. Dalakas MC. High-dose intravenous immunoglobulin in inflammatory myopathies: experience based on controlled clinical trials. Neurol Sci. 2003 Oct; 24 Suppl 4:S256-9. PMID: 14598055.
      Citations:    
    189. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003 Sep 20; 362(9388):971-82. PMID: 14511932.
      Citations:    
    190. Raju R, Vasconcelos O, Granger R, Dalakas MC. Expression of IFN-gamma-inducible chemokines in inclusion body myositis. J Neuroimmunol. 2003 Aug; 141(1-2):125-31. PMID: 12965263.
      Citations:    
    191. Ho NC, Sandusky S, Madike V, Francomano CA, Dalakas MC. Clinico-pathogenetic findings and management of chondrodystrophic myotonia (Schwartz-Jampel syndrome): a case report. BMC Neurol. 2003 Jul 2; 3:3. PMID: 12839625.
      Citations:    
    192. Dalakas MC, Clark WM. Strokes, thromboembolic events, and IVIg: rare incidents blemish an excellent safety record. Neurology. 2003 Jun 10; 60(11):1736-7. PMID: 12796522.
      Citations:    
    193. Hohlfeld R, Dalakas MC. Basic principles of immunotherapy for neurologic diseases. Semin Neurol. 2003 Jun; 23(2):121-32. PMID: 12894378.
      Citations:    
    194. Dalakas MC. Therapeutic approaches in patients with inflammatory myopathies. Semin Neurol. 2003 Jun; 23(2):199-206. PMID: 12894385.
      Citations:    
    195. Dalakas MC, Dagvadorj A, Goudeau B, Park KY, Takeda K, Simon-Casteras M, Vasconcelos O, Sambuughin N, Shatunov A, Nagle JW, Sivakumar K, Vicart P, Goldfarb LG. Progressive skeletal myopathy, a phenotypic variant of desmin myopathy associated with desmin mutations. Neuromuscul Disord. 2003 Mar; 13(3):252-8. PMID: 12609507.
      Citations:    
    196. Gold R, Dalakas MC, Toyka KV. Immunotherapy in autoimmune neuromuscular disorders. Lancet Neurol. 2003 Jan; 2(1):22-32. PMID: 12849298.
      Citations:    
    197. Vasconcelos OM, Dalakas MC. Stiff-person Syndrome. Curr Treat Options Neurol. 2003 Jan; 5(1):79-90. PMID: 12521565.
      Citations:    
    198. Kieseier BC, Dalakas MC, Hartung HP. Immune mechanisms in chronic inflammatory demyelinating neuropathy. Neurology. 2002 Dec 24; 59(12 Suppl 6):S7-12. PMID: 12499465.
      Citations:    
    199. Dalakas MC. Mechanisms of action of IVIg and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathies. Neurology. 2002 Dec 24; 59(12 Suppl 6):S13-21. PMID: 12499466.
      Citations:    
    200. Dalakas MC. Pro-inflammatory cytokines and motor neuron dysfunction: is there a connection in post-polio syndrome? J Neurol Sci. 2002 Dec 15; 205(1):5-8. PMID: 12409176.
      Citations:    
    201. Vasconcelos OM, Raju R, Dalakas MC. GNE mutations in an American family with quadriceps-sparing IBM and lack of mutations in s-IBM. Neurology. 2002 Dec 10; 59(11):1776-9. PMID: 12473769.
      Citations:    
    202. Dalakas MC. Muscle biopsy findings in inflammatory myopathies. Rheum Dis Clin North Am. 2002 Nov; 28(4):779-98, vi. PMID: 12506772.
      Citations:    
    203. Dalakas MC. Understanding the immunopathogenesis of inclusion-body myositis: present and future prospects. Rev Neurol (Paris). 2002 Oct; 158(10 Pt 1):948-58. PMID: 12407303.
      Citations:    
    204. Molloy FM, Dalakas MC, Floeter MK. Increased brainstem excitability in stiff-person syndrome. Neurology. 2002 Aug 13; 59(3):449-51. PMID: 12177385.
      Citations:    
    205. Dalakas MC. Blockade of blocking antibodies in Guillain-Barré syndromes: "unblocking" the mystery of action of intravenous immunoglobulin. Ann Neurol. 2002 Jun; 51(6):667-9. PMID: 12112069.
      Citations:    
    206. Arikawa-Hirasawa E, Le AH, Nishino I, Nonaka I, Ho NC, Francomano CA, Govindraj P, Hassell JR, Devaney JM, Spranger J, Stevenson RE, Iannaccone S, Dalakas MC, Yamada Y. Structural and functional mutations of the perlecan gene cause Schwartz-Jampel syndrome, with myotonic myopathy and chondrodysplasia. Am J Hum Genet. 2002 May; 70(5):1368-75. PMID: 11941538.
      Citations:    
    207. Dalakas MC. Inflammatory myopathies. Recent advances in pathogenesis and therapy. Adv Neurol. 2002; 88:253-71. PMID: 11908230.
      Citations:    
    208. Dalakas MC, Fujii M, Li M, Lutfi B, Kyhos J, McElroy B. High-dose intravenous immune globulin for stiff-person syndrome. N Engl J Med. 2001 Dec 27; 345(26):1870-6. PMID: 11756577.
      Citations:    
    209. Dalakas MC, Semino-Mora C, Leon-Monzon M. Mitochondrial alterations with mitochondrial DNA depletion in the nerves of AIDS patients with peripheral neuropathy induced by 2'3'-dideoxycytidine (ddC). Lab Invest. 2001 Nov; 81(11):1537-44. PMID: 11706061.
      Citations:    
    210. Dalakas MC, Li M, Fujii M, Jacobowitz DM. Stiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD65 antibodies. Neurology. 2001 Sep 11; 57(5):780-4. PMID: 11552003.
      Citations:    
    211. Dalakas MC. The molecular and cellular pathology of inflammatory muscle diseases. Curr Opin Pharmacol. 2001 Jun; 1(3):300-6. PMID: 11712755.
      Citations:    
    212. Li M, Dalakas MC. Abnormal desmin protein in myofibrillar myopathies caused by desmin gene mutations. Ann Neurol. 2001 Apr; 49(4):532-6. PMID: 11310634.
      Citations:    
    213. Dalakas MC, Koffman B, Fujii M, Spector S, Sivakumar K, Cupler E. A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM. Neurology. 2001 Feb 13; 56(3):323-7. PMID: 11171896.
      Citations:    
    214. Dalakas MC, Fujii M, Li M, McElroy B. The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome. Neurology. 2000 Nov 28; 55(10):1531-5. PMID: 11094109.
      Citations:    
    215. Park KY, Dalakas MC, Goebel HH, Ferrans VJ, Semino-Mora C, Litvak S, Takeda K, Goldfarb LG. Desmin splice variants causing cardiac and skeletal myopathy. J Med Genet. 2000 Nov; 37(11):851-7. PMID: 11073539.
      Citations:    
    216. Sandbrink F, Syed NA, Fujii MD, Dalakas MC, Floeter MK. Motor cortex excitability in stiff-person syndrome. Brain. 2000 Nov; 123 ( Pt 11):2231-9. PMID: 11050023.
      Citations:    
    217. Amemiya K, Granger RP, Dalakas MC. Clonal restriction of T-cell receptor expression by infiltrating lymphocytes in inclusion body myositis persists over time. Studies in repeated muscle biopsies. Brain. 2000 Oct; 123 ( Pt 10):2030-9. PMID: 11004120.
      Citations:    
    218. Miller KD, Cameron M, Wood LV, Dalakas MC, Kovacs JA. Lactic acidosis and hepatic steatosis associated with use of stavudine: report of four cases. Ann Intern Med. 2000 Aug 1; 133(3):192-6. PMID: 10906833.
      Citations:    
    219. Murata K, Dalakas MC. Expression of the co-stimulatory molecule BB-1, the ligands CTLA-4 and CD28 and their mRNAs in chronic inflammatory demyelinating polyneuropathy. Brain. 2000 Aug; 123 ( Pt 8):1660-6. PMID: 10908195.
      Citations:    
    220. Peng A, Koffman BM, Malley JD, Dalakas MC. Disease progression in sporadic inclusion body myositis: observations in 78 patients. Neurology. 2000 Jul 25; 55(2):296-8. PMID: 10908910.
      Citations:    
    221. Li M, Dalakas MC. Expression of human IAP-like protein in skeletal muscle: a possible explanation for the rare incidence of muscle fiber apoptosis in T-cell mediated inflammatory myopathies. J Neuroimmunol. 2000 Jul 1; 106(1-2):1-5. PMID: 10814776.
      Citations:    
    222. Park KY, Dalakas MC, Semino-Mora C, Lee HS, Litvak S, Takeda K, Ferrans VJ, Goldfarb LG. Sporadic cardiac and skeletal myopathy caused by a de novo desmin mutation. Clin Genet. 2000 Jun; 57(6):423-9. PMID: 10905661.
      Citations:    
    223. Li M, Dalakas MC. The muscle mitogen-activated protein kinase is altered in sporadic inclusion body myositis. Neurology. 2000 Apr 25; 54(8):1665-70. PMID: 10762511.
      Citations:    
    224. Dalakas MC, Park KY, Semino-Mora C, Lee HS, Sivakumar K, Goldfarb LG. Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene. N Engl J Med. 2000 Mar 16; 342(11):770-80. PMID: 10717012.
      Citations:    
    225. Amemiya K, Semino-Mora C, Granger RP, Dalakas MC. Downregulation of TGF-beta1 mRNA and protein in the muscles of patients with inflammatory myopathies after treatment with high-dose intravenous immunoglobulin. Clin Immunol. 2000 Feb; 94(2):99-104. PMID: 10637094.
      Citations:    
    226. Choi YC, Dalakas MC. Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies. Neurology. 2000 Jan 11; 54(1):65-71. PMID: 10636127.
      Citations:    
    227. Tawil R, McDermott MP, Brown R, Shapiro BC, Ptacek LJ, McManis PG, Dalakas MC, Spector SA, Mendell JR, Hahn AF, Griggs RC. Randomized trials of dichlorphenamide in the periodic paralyses. Working Group on Periodic Paralysis. Ann Neurol. 2000 Jan; 47(1):46-53. PMID: 10632100.
      Citations:    
    228. Dalakas MC. Intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: present status and practical therapeutic guidelines. Muscle Nerve. 1999 Nov; 22(11):1479-97. PMID: 10514226.
      Citations:    
    229. Levy LM, Dalakas MC, Floeter MK. The stiff-person syndrome: an autoimmune disorder affecting neurotransmission of gamma-aminobutyric acid. Ann Intern Med. 1999 Oct 5; 131(7):522-30. PMID: 10507962.
      Citations:    
    230. Murata K, Dalakas MC. Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies. Am J Pathol. 1999 Aug; 155(2):453-60. PMID: 10433938.
      Citations:    
    231. Dalakas MC. Advances in chronic inflammatory demyelinating polyneuropathy: disease variants and inflammatory response mediators and modifiers. Curr Opin Neurol. 1999 Aug; 12(4):403-9. PMID: 10555828.
      Citations:    
    232. Weeks RA, Gerloff C, Honda M, Dalakas MC, Hallett M. Movement-related cerebellar activation in the absence of sensory input. J Neurophysiol. 1999 Jul; 82(1):484-8. PMID: 10400975.
      Citations:    
    233. Weiss MD, Dalakas MC, Lauter CJ, Willison HJ, Quarles RH. Variability in the binding of anti-MAG and anti-SGPG antibodies to target antigens in demyelinating neuropathy and IgM paraproteinemia. J Neuroimmunol. 1999 Mar 1; 95(1-2):174-84. PMID: 10229128.
      Citations:    
    234. Siegel H, McCutchen C, Dalakas MC, Freeman A, Graham B, Alling D, Sato S. Physiologic events initiating REM sleep in patients with the postpolio syndrome. Neurology. 1999 Feb; 52(3):516-22. PMID: 10025780.
      Citations:    
    235. Schneider C, Dalakas MC, Toyka KV, Said G, Hartung HP, Gold R. T-cell apoptosis in inflammatory neuromuscular disorders associated with human immunodeficiency virus infection. Arch Neurol. 1999 Jan; 56(1):79-83. PMID: 9923764.
      Citations:    
    236. Dalakas MC. Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases. Neurology. 1998 Dec; 51(6 Suppl 5):S2-8. PMID: 9851723.
      Citations:    
    237. Dalakas MC. Controlled studies with high-dose intravenous immunoglobulin in the treatment of dermatomyositis, inclusion body myositis, and polymyositis. Neurology. 1998 Dec; 51(6 Suppl 5):S37-45. PMID: 9851729.
      Citations:    
    238. Weiss MD, Luciano CA, Semino-Mora C, Dalakas MC, Quarles RH. Molecular mimicry in chronic inflammatory demyelinating polyneuropathy and melanoma. Neurology. 1998 Dec; 51(6):1738-41. PMID: 9855537.
      Citations:    
    239. Dalakas MC. Molecular immunology and genetics of inflammatory muscle diseases. Arch Neurol. 1998 Dec; 55(12):1509-12. PMID: 9865793.
      Citations:    
    240. Sambuughin N, Sivakumar K, Selenge B, Lee HS, Friedlich D, Baasanjav D, Dalakas MC, Goldfarb LG. Autosomal dominant distal spinal muscular atrophy type V (dSMA-V) and Charcot-Marie-Tooth disease type 2D (CMT2D) segregate within a single large kindred and map to a refined region on chromosome 7p15. J Neurol Sci. 1998 Nov 26; 161(1):23-8. PMID: 9879677.
      Citations:    
    241. Semino-Mora C, Dalakas MC. Rimmed vacuoles with beta-amyloid and ubiquitinated filamentous deposits in the muscles of patients with long-standing denervation (postpoliomyelitis muscular atrophy): similarities with inclusion body myositis. Hum Pathol. 1998 Oct; 29(10):1128-33. PMID: 9781653.
      Citations:    
    242. Goldfarb LG, Park KY, Cervenáková L, Gorokhova S, Lee HS, Vasconcelos O, Nagle JW, Semino-Mora C, Sivakumar K, Dalakas MC. Missense mutations in desmin associated with familial cardiac and skeletal myopathy. Nat Genet. 1998 Aug; 19(4):402-3. PMID: 9697706.
      Citations:    
    243. Samii A, Lopez-Devine J, Wasserman EM, Dalakas MC, Clark K, Grafman J, Hallett M. Normal postexercise facilitation and depression of motor evoked potentials in postpolio patients. Muscle Nerve. 1998 Jul; 21(7):948-50. PMID: 9626258.
      Citations:    
    244. Koffman BM, Sivakumar K, Simonis T, Stroncek D, Dalakas MC. HLA allele distribution distinguishes sporadic inclusion body myositis from hereditary inclusion body myopathies. J Neuroimmunol. 1998 Apr 15; 84(2):139-42. PMID: 9628455.
      Citations:    
    245. Dalakas MC, Mock V, Hawkins MJ. Fatigue: definitions, mechanisms, and paradigms for study. Semin Oncol. 1998 Feb; 25(1 Suppl 1):48-53. PMID: 9482540.
      Citations:    
    246. Hott JS, Dalakas MC, Sung C, Hallett M, Youle RJ. Skeletal muscle-specific immunotoxin for the treatment of focal muscle spasm. Neurology. 1998 Feb; 50(2):485-91. PMID: 9484377.
      Citations:    
    247. Koffman BM, Rugiero M, Dalakas MC. Immune-mediated conditions and antibodies associated with sporadic inclusion body myositis. Muscle Nerve. 1998 Jan; 21(1):115-7. PMID: 9427231.
      Citations:    
    248. Illa I, Dalakas MC. Dermatomyositis, polymyositis and inclusion body myositis: current concepts. Rev Neurol (Paris). 1998 Jan; 154(1):13-6. PMID: 9773019.
      Citations:    
    249. Spector SA, Lemmer JT, Koffman BM, Fleisher TA, Feuerstein IM, Hurley BF, Dalakas MC. Safety and efficacy of strength training in patients with sporadic inclusion body myositis. Muscle Nerve. 1997 Oct; 20(10):1242-8. PMID: 9324080.
      Citations:    
    250. Sivakumar K, Dalakas MC. Inclusion body myositis and myopathies. Curr Opin Neurol. 1997 Oct; 10(5):413-20. PMID: 9330888.
      Citations:    
    251. Castelli JC, Hassel BA, Wood KA, Li XL, Amemiya K, Dalakas MC, Torrence PF, Youle RJ. A study of the interferon antiviral mechanism: apoptosis activation by the 2-5A system. J Exp Med. 1997 Sep 15; 186(6):967-72. PMID: 9294150.
      Citations:    
    252. Koffman BM, Dalakas MC. Effect of high-dose intravenous immunoglobulin on serum chemistry, hematology, and lymphocyte subpopulations: assessments based on controlled treatment trials in patients with neurological diseases. Muscle Nerve. 1997 Sep; 20(9):1102-7. PMID: 9270664.
      Citations:    
    253. Dalakas MC. Intravenous immune globulin therapy for neurologic diseases. Ann Intern Med. 1997 May 1; 126(9):721-30. PMID: 9139559.
      Citations:    
    254. Sivakumar K, Semino-Mora C, Dalakas MC. An inflammatory, familial, inclusion body myositis with autoimmune features and a phenotype identical to sporadic inclusion body myositis. Studies in three families. Brain. 1997 Apr; 120 ( Pt 4):653-61. PMID: 9153127.
      Citations:    
    255. Sekul EA, Chow C, Dalakas MC. Magnetic resonance imaging of the forearm as a diagnostic aid in patients with sporadic inclusion body myositis. Neurology. 1997 Apr; 48(4):863-6. PMID: 9109868.
      Citations:    
    256. Semino-Mora C, Leon-Monzon M, Dalakas MC. Mitochondrial and cellular toxicity induced by fialuridine in human muscle in vitro. Lab Invest. 1997 Apr; 76(4):487-95. PMID: 9111511.
      Citations:    
    257. Dalakas MC, Sonies B, Dambrosia J, Sekul E, Cupler E, Sivakumar K. Treatment of inclusion-body myositis with IVIg: a double-blind, placebo-controlled study. Neurology. 1997 Mar; 48(3):712-6. PMID: 9065553.
      Citations:    
    258. Dalakas MC, Illa I, Gallardo E, Juarez C. Inclusion body myositis and paraproteinemia: incidence and immunopathologic correlations. Ann Neurol. 1997 Jan; 41(1):100-4. PMID: 9005871.
      Citations:    
    259. Luciano CA, Dalakas MC. Inclusion body myositis: no evidence for a neurogenic component. Neurology. 1997 Jan; 48(1):29-33. PMID: 9008489.
      Citations:    
    260. Cupler EJ, Leon-Monzon M, Miller J, Semino-Mora C, Anderson TL, Dalakas MC. Inclusion body myositis in HIV-1 and HTLV-1 infected patients. Brain. 1996 Dec; 119 ( Pt 6):1887-93. PMID: 9009995.
      Citations:    
    261. Basta M, Illa I, Dalakas MC. Increased in vitro uptake of the complement C3b in the serum of patients with Guillain-Barré syndrome, myasthenia gravis and dermatomyositis. J Neuroimmunol. 1996 Dec; 71(1-2):227-9. PMID: 8982124.
      Citations:    
    262. Schneider C, Gold R, Dalakas MC, Schmied M, Lassmann H, Toyka KV, Hartung HP. MHC class I-mediated cytotoxicity does not induce apoptosis in muscle fibers nor in inflammatory T cells: studies in patients with polymyositis, dermatomyositis, and inclusion body myositis. J Neuropathol Exp Neurol. 1996 Dec; 55(12):1205-9. PMID: 8957443.
      Citations:    
    263. Dalakas MC, Quarles RH, Farrer RG, Dambrosia J, Soueidan S, Stein DP, Cupler E, Sekul EA, Otero C. A controlled study of intravenous immunoglobulin in demyelinating neuropathy with IgM gammopathy. Ann Neurol. 1996 Nov; 40(5):792-5. PMID: 8957021.
      Citations:    
    264. Luciano CA, Sivakumar K, Spector SA, Dalakas MC. Electrophysiologic and histologic studies in clinically unaffected muscles of patients with prior paralytic poliomyelitis. Muscle Nerve. 1996 Nov; 19(11):1413-20. PMID: 8874398.
      Citations:    
    265. Spector SA, Gordon PL, Feuerstein IM, Sivakumar K, Hurley BF, Dalakas MC. Strength gains without muscle injury after strength training in patients with postpolio muscular atrophy. Muscle Nerve. 1996 Oct; 19(10):1282-90. PMID: 8808654.
      Citations:    
    266. Sivakumar K, Dalakas MC. The spectrum of familial inclusion body myopathies in 13 families and a description of a quadriceps-sparing phenotype in non-Iranian Jews. Neurology. 1996 Oct; 47(4):977-84. PMID: 8857730.
      Citations:    
    267. Cupler EJ, Otero C, Hench K, Luciano C, Dalakas MC. Acetylcholine receptor antibodies as a marker of treatable fatigue in HIV-1 infected individuals. Muscle Nerve. 1996 Sep; 19(9):1186-8. PMID: 8761282.
      Citations:    
    268. Cervernáková L, Sivakumar K, Nagle J, Dalakas MC, Goldfarb LG. Is hereditary inclusion body myopathy a "familial prion disease" ? Ann Neurol. 1996 Jul; 40(1):128. PMID: 8687183.
      Citations:    
    269. Dalakas MC, Sivakumar K. The immunopathologic and inflammatory differences between dermatomyositis, polymyositis and sporadic inclusion body myositis. Curr Opin Neurol. 1996 Jun; 9(3):235-9. PMID: 8839618.
      Citations:    
    270. Farrer RG, Dalakas MC, Quarles RH. Multiple antibodies to nerve glycoconjugates in a patient with neuropathy and monoclonal IgA gammopathy. J Neuroimmunol. 1996 May; 66(1-2):71-6. PMID: 8964916.
      Citations:    
    271. Poetter K, Jiang H, Hassanzadeh S, Master SR, Chang A, Dalakas MC, Rayment I, Sellers JR, Fananapazir L, Epstein ND. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet. 1996 May; 13(1):63-9. PMID: 8673105.
      Citations:    
    272. Dalakas MC. Clinical benefits and immunopathological correlates of intravenous immune globulin in the treatment of inflammatory myopathies. Clin Exp Immunol. 1996 May; 104 Suppl 1:55-60. PMID: 8625545.
      Citations:    
    273. Sivakumar K, Vasconcelos O, Goldfarb L, Dalakas MC. Late-onset muscle weakness in partial phosphofructokinase deficiency: a unique myopathy with vacuoles, abnormal mitochondria, and absence of the common exon 5/intron 5 junction point mutation. Neurology. 1996 May; 46(5):1337-42. PMID: 8628478.
      Citations:    
    274. Dalakas MC, Quarles RH. Autoimmune ataxic neuropathies (sensory ganglionopathies): are glycolipids the responsible autoantigens? Ann Neurol. 1996 Apr; 39(4):419-22. PMID: 8619518.
      Citations:    
    275. Quarles RH, Dalakas MC. Do anti-ganglioside antibodies cause human peripheral neuropathies? J Clin Invest. 1996 Mar 1; 97(5):1136-7. PMID: 8636423.
      Citations:    
    276. Dalakas MC, Cupler EJ. Neuropathies in HIV infection. Baillieres Clin Neurol. 1996 Mar; 5(1):199-218. PMID: 8732208.
      Citations:    
    277. Rubio SI, Naha KK, Sivakumar K, Dalakas MC, Poretsky L. Coexistence of diabetes and phosphofructokinase deficiency. Endocr Pract. 1996 Mar-Apr; 2(2):100-2. PMID: 15251550.
      Citations:    
    278. Goldstein DS, McRae A, Holmes C, Dalakas MC. Autoimmune autonomic failure in a patient with myeloma-associated Shy-Drager syndrome. Clin Auton Res. 1996 Feb; 6(1):17-21. PMID: 8924751.
      Citations:    
    279. Dalakas MC. Update on the use of intravenous immune globulin in the treatment of patients with inflammatory muscle disease. J Clin Immunol. 1995 Nov; 15(6 Suppl):70S-75S. PMID: 8613495.
      Citations:    
    280. Vasconcelos O, Sivakumar K, Dalakas MC, Quezado M, Nagle J, Leon-Monzon M, Dubnick M, Gajdusek DC, Goldfarb LG. Nonsense mutation in the phosphofructokinase muscle subunit gene associated with retention of intron 10 in one of the isolated transcripts in Ashkenazi Jewish patients with Tarui disease. Proc Natl Acad Sci U S A. 1995 Oct 24; 92(22):10322-6. PMID: 7479776.
      Citations:    
    281. Dalakas MC. Images in clinical medicine. Calcifications in dermatomyositis. N Engl J Med. 1995 Oct 12; 333(15):978. PMID: 7666918.
      Citations:    
    282. Bitton RJ, Figg WD, Venzon DJ, Dalakas MC, Bowden C, Headlee D, Reed E, Myers CE, Cooper MR. Pharmacologic variables associated with the development of neurologic toxicity in patients treated with suramin. J Clin Oncol. 1995 Sep; 13(9):2223-9. PMID: 7666080.
      Citations:    
    283. Illa I, Ortiz N, Gallard E, Juarez C, Grau JM, Dalakas MC. Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides. Ann Neurol. 1995 Aug; 38(2):218-24. PMID: 7654069.
      Citations:    
    284. Sivakumar K, Cervenáková L, Dalakas MC, Leon-Monzon M, Isaacson SH, Nagle JW, Vasconcelos O, Goldfarb LG. Exons 16 and 17 of the amyloid precursor protein gene in familial inclusion body myopathy. Ann Neurol. 1995 Aug; 38(2):267-9. PMID: 7654077.
      Citations:    
    285. O'Hanlon TP, Dalakas MC, Plotz PH, Miller FW. The alpha beta T-cell receptor repertoire in idiopathic inflammatory myopathies: distinct patterns of gene expression by muscle-infiltrating lymphocytes in different clinical and serologic groups. Ann N Y Acad Sci. 1995 Jul 7; 756:410-3. PMID: 7645860.
      Citations:    
    286. Dalakas MC, Illa I, Leon-Monzon M. Intramuscular injections and vaccine-associated poliomyelitis. N Engl J Med. 1995 Jul 6; 333(1):62; author reply 64. PMID: 7777001.
      Citations:    
    287. Sinnwell TM, Sivakumar K, Soueidan S, Jay C, Frank JA, McLaughlin AC, Dalakas MC. Metabolic abnormalities in skeletal muscle of patients receiving zidovudine therapy observed by 31P in vivo magnetic resonance spectroscopy. J Clin Invest. 1995 Jul; 96(1):126-31. PMID: 7615782.
      Citations:    
    288. Dalakas MC, Illa I. Common variable immunodeficiency and inclusion body myositis: a distinct myopathy mediated by natural killer cells. Ann Neurol. 1995 Jun; 37(6):806-10. PMID: 7778855.
      Citations:    
    289. O'Hanlon TP, Messersmith WA, Dalakas MC, Plotz PH, Miller FW. Gamma delta T cell receptor gene expression by muscle-infiltrating lymphocytes in the idiopathic inflammatory myopathies. Clin Exp Immunol. 1995 Jun; 100(3):519-28. PMID: 7774065.
      Citations:    
    290. Dalakas MC. Opening remarks. On post-polio syndrome and in honor of Dr. Albert B. Sabin. Ann N Y Acad Sci. 1995 May 25; 753:xi-xiv. PMID: 7611615.
      Citations:    
    291. Grafman J, Clark K, Richardson D, Dinsmore S, Stein D, Dalakas MC. Neuropsychology of post-polio syndrome. Ann N Y Acad Sci. 1995 May 25; 753:103-10. PMID: 7611618.
      Citations:    
    292. Dalakas MC. Post-polio syndrome 12 years later. How it all started. Ann N Y Acad Sci. 1995 May 25; 753:11-8. PMID: 7611619.
      Citations:    
    293. Dalakas MC. Pathogenetic mechanisms of post-polio syndrome: morphological, electrophysiological, virological, and immunological correlations. Ann N Y Acad Sci. 1995 May 25; 753:167-85. PMID: 7611626.
      Citations:    
    294. Isaacson SH, Sivakumar K, Asher DM, Pomeroy KL, Ramos-Alvarez M, Gibbs CJ, Gajdusek DC, Dalakas MC. Cellular localization of poliovirus RNA in the spinal cord during acute paralytic poliomyelitis. Ann N Y Acad Sci. 1995 May 25; 753:194-200. PMID: 7611628.
      Citations:    
    295. Leon-Monzon ME, Dalakas MC. Detection of poliovirus antibodies and poliovirus genome in patients with the post-polio syndrome. Ann N Y Acad Sci. 1995 May 25; 753:208-18. PMID: 7611630.
      Citations:    
    296. Stein DP, Dambrosia JM, Dalakas MC. A double-blind, placebo-controlled trial of amantadine for the treatment of fatigue in patients with the post-polio syndrome. Ann N Y Acad Sci. 1995 May 25; 753:296-302. PMID: 7611638.
      Citations:    
    297. Dinsmore S, Dambrosia J, Dalakas MC. A double-blind, placebo-controlled trial of high-dose prednisone for the treatment of post-poliomyelitis syndrome. Ann N Y Acad Sci. 1995 May 25; 753:303-13. PMID: 7611639.
      Citations:    
    298. Dalakas MC. How to design a therapeutic study in patients with the post-polio syndrome. Methodological concerns and status of present therapies. Ann N Y Acad Sci. 1995 May 25; 753:314-20. PMID: 7611640.
      Citations:    
    299. Illa I, Leon-Monzon M, Agboatwalla M, Ilyas A, Latov N, Dalakas MC. Antiganglioside antibodies in patients with acute polio and post-polio syndrome. Ann N Y Acad Sci. 1995 May 25; 753:374-7. PMID: 7611648.
      Citations:    
    300. Nee L, Dambrosia J, Bern E, Eldridge R, Dalakas MC. Post-polio syndrome in twins and their siblings. Evidence that post-polio syndrome can develop in patients with nonparalytic polio. Ann N Y Acad Sci. 1995 May 25; 753:378-80. PMID: 7611649.
      Citations:    
    301. Luciano CA, Sivakumar K, Spector SA, Dalakas MC. Reinnervation in clinically unaffected muscles of patients with prior paralytic poliomyelitis. Correlation between macroelectromyography and histology. Ann N Y Acad Sci. 1995 May 25; 753:394-6. PMID: 7611654.
      Citations:    
    302. Sivakumar K, Sinnwell T, Yildiz E, McLaughlin A, Dalakas MC. Study of fatigue in muscles of patients with post-polio syndrome by in vivo [31P]magnetic resonance spectroscopy. A metabolic cause for fatigue. Ann N Y Acad Sci. 1995 May 25; 753:397-401. PMID: 7611655.
      Citations:    
    303. Spector SA, Gordon PL, Yildiz E, Sivakumar K, Hurley BF, Dalakas MC. Effect of strength training in patients with post-polio syndrome. A preliminary report. Ann N Y Acad Sci. 1995 May 25; 753:402-4. PMID: 7611656.
      Citations:    
    304. Leon-Monzon ME, Illa I, Dalakas MC. Expression of poliovirus receptor in human spinal cord and muscle. Ann N Y Acad Sci. 1995 May 25; 753:48-57. PMID: 7611659.
      Citations:    
    305. Illa I, Leon-Monzon M, Agboatwalla M, Dure-Samin A, Dalakas MC. Role of the muscle in acute poliomyelitis infection. Ann N Y Acad Sci. 1995 May 25; 753:58-67. PMID: 7611660.
      Citations:    
    306. Dalakas MC. The post-polio syndrome as an evolved clinical entity. Definition and clinical description. Ann N Y Acad Sci. 1995 May 25; 753:68-80. PMID: 7611661.
      Citations:    
    307. Sonies BC, Dalakas MC. Progression of oral-motor and swallowing symptoms in the post-polio syndrome. Ann N Y Acad Sci. 1995 May 25; 753:87-95. PMID: 7611663.
      Citations:    
    308. Dalakas MC. Basic aspects of neuroimmunology as they relate to immunotherapeutic targets: present and future prospects. Ann Neurol. 1995 May; 37 Suppl 1:S2-13. PMID: 8968213.
      Citations:    
    309. Dalakas MC. Immunopathogenesis of inflammatory myopathies. Ann Neurol. 1995 May; 37 Suppl 1:S74-86. PMID: 8968219.
      Citations:    
    310. Drosos AA, Dalakas MC. Identification of macrophages in the muscle biopsy preparations: a comparative study using specific monoclonal antimacrophage antibodies and acid phosphatase reaction. Muscle Nerve. 1995 Feb; 18(2):242-4. PMID: 7529891.
      Citations:    
    311. Cupler EJ, Danon MJ, Jay C, Hench K, Ropka M, Dalakas MC. Early features of zidovudine-associated myopathy: histopathological findings and clinical correlations. Acta Neuropathol. 1995; 90(1):1-6. PMID: 7572071.
      Citations:    
    312. Dalakas MC. Current treatment of the inflammatory myopathies. Curr Opin Rheumatol. 1994 Nov; 6(6):595-601. PMID: 7865379.
      Citations:    
    313. Semino-Mora MC, Leon-Monzon ME, Dalakas MC. The effect of L-carnitine on the AZT-induced destruction of human myotubes. Part II: Treatment with L-carnitine improves the AZT-induced changes and prevents further destruction. Lab Invest. 1994 Nov; 71(5):773-81. PMID: 7967528.
      Citations:    
    314. Basta M, Dalakas MC. High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments. J Clin Invest. 1994 Nov; 94(5):1729-35. PMID: 7962520.
      Citations:    
    315. Clark K, Dinsmore S, Grafman J, Dalakas MC. A personality profile of patients diagnosed with post-polio syndrome. Neurology. 1994 Oct; 44(10):1809-11. PMID: 7936226.
      Citations:    
    316. Leon-Monzon M, Illa I, Dalakas MC. Polymyositis in patients infected with human T-cell leukemia virus type I: the role of the virus in the cause of the disease. Ann Neurol. 1994 Oct; 36(4):643-9. PMID: 7944297.
      Citations:    
    317. Dalakas MC, Stein DP, Otero C, Sekul E, Cupler EJ, McCrosky S. Effect of high-dose intravenous immunoglobulin on amyotrophic lateral sclerosis and multifocal motor neuropathy. Arch Neurol. 1994 Sep; 51(9):861-4. PMID: 8080385.
      Citations:    
    318. Sivakumar K, Dalakas MC. Autoimmune syndrome induced by omeprazole. Lancet. 1994 Aug 27; 344(8922):619-20. PMID: 7914991.
      Citations:    
    319. Sekul EA, Cupler EJ, Dalakas MC. Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors. Ann Intern Med. 1994 Aug 15; 121(4):259-62. PMID: 8037406.
      Citations:    
    320. Semino-Mora MC, Leon-Monzon ME, Dalakas MC. Effect of L-carnitine on the zidovudine-induced destruction of human myotubes. Part I: L-carnitine prevents the myotoxicity of AZT in vitro. Lab Invest. 1994 Jul; 71(1):102-12. PMID: 7518879.
      Citations:    
    321. O'Hanlon TP, Dalakas MC, Plotz PH, Miller FW. The alpha beta T-cell receptor repertoire in inclusion body myositis: diverse patterns of gene expression by muscle-infiltrating lymphocytes. J Autoimmun. 1994 Jun; 7(3):321-33. PMID: 7916906.
      Citations:    
    322. Dalakas MC. How to diagnose and treat the inflammatory myopathies. Semin Neurol. 1994 Jun; 14(2):137-45. PMID: 7984828.
      Citations:    
    323. Dalakas MC. Neuroimmunotherapy: a practical approach to the treatment of immune-mediated neurologic diseases. Semin Neurol. 1994 Jun; 14(2):97-105. PMID: 7984835.
      Citations:    
    324. Dalakas MC, Leon-Monzon ME, Bernardini I, Gahl WA, Jay CA. Zidovudine-induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage. Ann Neurol. 1994 Apr; 35(4):482-7. PMID: 8154877.
      Citations:    
    325. O'Hanlon TP, Dalakas MC, Plotz PH, Miller FW. Predominant TCR-alpha beta variable and joining gene expression by muscle-infiltrating lymphocytes in the idiopathic inflammatory myopathies. J Immunol. 1994 Mar 1; 152(5):2569-76. PMID: 8133064.
      Citations:    
    326. Dalakas MC. High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events. Neurology. 1994 Feb; 44(2):223-6. PMID: 8309562.
      Citations:    
    327. Dalakas MC, Illa I, Dambrosia JM, Soueidan SA, Stein DP, Otero C, Dinsmore ST, McCrosky S. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med. 1993 Dec 30; 329(27):1993-2000. PMID: 8247075.
      Citations:    
    328. Dalakas MC. Retroviruses and inflammatory myopathies in humans and primates. Baillieres Clin Neurol. 1993 Nov; 2(3):659-91. PMID: 8156147.
      Citations:    
    329. Sekul EA, Dalakas MC. Inclusion body myositis: new concepts. Semin Neurol. 1993 Sep; 13(3):256-63. PMID: 8272596.
      Citations:    
    330. Gahl WA, Bernardini IM, Dalakas MC, Markello TC, Krasnewich DM, Charnas LR. Muscle carnitine repletion by long-term carnitine supplementation in nephropathic cystinosis. Pediatr Res. 1993 Aug; 34(2):115-9. PMID: 8233709.
      Citations:    
    331. Illa I, Dinsmore S, Dalakas MC. Immune-mediated mechanisms and immune activation of fibroblasts in the pathogenesis of eosinophilia-myalgia syndrome induced by L-tryptophan. Hum Pathol. 1993 Jul; 24(7):702-9. PMID: 8100551.
      Citations:    
    332. Fananapazir L, Dalakas MC, Cyran F, Cohn G, Epstein ND. Missense mutations in the beta-myosin heavy-chain gene cause central core disease in hypertrophic cardiomyopathy. Proc Natl Acad Sci U S A. 1993 May 1; 90(9):3993-7. PMID: 8483915.
      Citations:    
    333. Soueidan SA, Dalakas MC. Treatment of inclusion-body myositis with high-dose intravenous immunoglobulin. Neurology. 1993 May; 43(5):876-9. PMID: 8492940.
      Citations:    
    334. Leon-Monzon M, Lamperth L, Dalakas MC. Search for HIV proviral DNA and amplified sequences in the muscle biopsies of patients with HIV polymyositis. Muscle Nerve. 1993 Apr; 16(4):408-13. PMID: 8455655.
      Citations:    
    335. Soueidan SA, Dalakas MC. Treatment of autoimmune neuromuscular diseases with high-dose intravenous immune globulin. Pediatr Res. 1993 Jan; 33(1 Suppl):S95-100. PMID: 8433882.
      Citations:    
    336. Dalakas MC. Elevated creatine kinase level in postpolio syndrome. JAMA. 1992 Dec 9; 268(22):3248. PMID: 1433769.
      Citations:    
    337. Gahl WA, Charnas L, Markello TC, Bernardini I, Ishak KG, Dalakas MC. Parenchymal organ cystine depletion with long-term cysteamine therapy. Biochem Med Metab Biol. 1992 Dec; 48(3):275-85. PMID: 1476793.
      Citations:    
    338. Dalakas MC. Clinical, immunopathologic, and therapeutic considerations of inflammatory myopathies. Clin Neuropharmacol. 1992 Oct; 15(5):327-51. PMID: 1423335.
      Citations:    
    339. Dalakas MC. Inflammatory and toxic myopathies. Curr Opin Neurol Neurosurg. 1992 Oct; 5(5):645-54. PMID: 1327303.
      Citations:    
    340. Leon-Monzon M, Dalakas MC. Absence of persistent infection with enteroviruses in muscles of patients with inflammatory myopathies. Ann Neurol. 1992 Aug; 32(2):219-22. PMID: 1324633.
      Citations:    
    341. Daune GC, Farrer RG, Dalakas MC, Quarles RH. Sensory neuropathy associated with monoclonal immunoglobulin M to GD1b ganglioside. Ann Neurol. 1992 Jun; 31(6):683-5. PMID: 1381168.
      Citations:    
    342. Leff RL, Love LA, Miller FW, Greenberg SJ, Klein EA, Dalakas MC, Plotz PH. Viruses in idiopathic inflammatory myopathies: absence of candidate viral genomes in muscle. Lancet. 1992 May 16; 339(8803):1192-5. PMID: 1349938.
      Citations:    
    343. Ilyas AA, Cook SD, Dalakas MC, Mithen FA. Anti-MAG IgM paraproteins from some patients with polyneuropathy associated with IgM paraproteinemia also react with sulfatide. J Neuroimmunol. 1992 Mar; 37(1-2):85-92. PMID: 1372333.
      Citations:    
    344. Illa I, Leon-Monzon M, Dalakas MC. Regenerating and denervated human muscle fibers and satellite cells express neural cell adhesion molecule recognized by monoclonal antibodies to natural killer cells. Ann Neurol. 1992 Jan; 31(1):46-52. PMID: 1371910.
      Citations:    
    345. Ilyas AA, Mithen FA, Dalakas MC, Chen ZW, Cook SD. Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Sci. 1992 Jan; 107(1):111-21. PMID: 1578228.
      Citations:    
    346. Pezeshkpour G, Illa I, Dalakas MC. Ultrastructural characteristics and DNA immunocytochemistry in human immunodeficiency virus and zidovudine-associated myopathies. Hum Pathol. 1991 Dec; 22(12):1281-8. PMID: 1748434.
      Citations:    
    347. Lamperth L, Dalakas MC, Dagani F, Anderson J, Ferrari R. Abnormal skeletal and cardiac muscle mitochondria induced by zidovudine (AZT) in human muscle in vitro and in an animal model. Lab Invest. 1991 Dec; 65(6):742-51. PMID: 1753716.
      Citations:    
    348. Dalakas MC. Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med. 1991 Nov 21; 325(21):1487-98. PMID: 1658649.
      Citations:    
    349. Leff RL, Burgess SH, Miller FW, Love LA, Targoff IN, Dalakas MC, Joffe MM, Plotz PH. Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy in patients with anti-Jo-1 and anti-signal recognition particle autoantibodies. Arthritis Rheum. 1991 Nov; 34(11):1391-6. PMID: 1953817.
      Citations:    
    350. Ilyas AA, Mithen FA, Dalakas MC, Wargo M, Chen ZW, Bielory L, Cook SD. Antibodies to sulfated glycolipids in Guillain-Barré syndrome. J Neurol Sci. 1991 Sep; 105(1):108-17. PMID: 1795163.
      Citations:    
    351. Fraser DD, Frank JA, Dalakas MC. Inflammatory myopathies: MR imaging and spectroscopy. Radiology. 1991 May; 179(2):341-2; discussion 343-4. PMID: 2064655.
      Citations:    
    352. Sonies BC, Dalakas MC. Dysphagia in patients with the post-polio syndrome. N Engl J Med. 1991 Apr 25; 324(17):1162-7. PMID: 2011159.
      Citations:    
    353. Crofford LJ, Rader JI, Dalakas MC, Hill RH, Page SW, Needham LL, Brady LS, Heyes MP, Wilder RL, Gold PW, et al. L-tryptophan implicated in human eosinophilia-myalgia syndrome causes fasciitis and perimyositis in the Lewis rat. J Clin Invest. 1990 Nov; 86(5):1757-63. PMID: 2243145.
      Citations:    
    354. La Rocca RV, Meer J, Gilliatt RW, Stein CA, Cassidy J, Myers CE, Dalakas MC. Suramin-induced polyneuropathy. Neurology. 1990 Jun; 40(6):954-60. PMID: 2161094.
      Citations:    
    355. Horowits R, Dalakas MC, Podolsky RJ. Single skinned muscle fibers in Duchenne muscular dystrophy generate normal force. Ann Neurol. 1990 Jun; 27(6):636-41. PMID: 2360800.
      Citations:    
    356. Dalakas MC, Illa I, Pezeshkpour GH, Laukaitis JP, Cohen B, Griffin JL. Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med. 1990 Apr 19; 322(16):1098-105. PMID: 2320079.
      Citations:    
    357. Boumpas DT, Patronas NJ, Dalakas MC, Hakim CA, Klippel JH, Balow JE. Acute transverse myelitis in systemic lupus erythematosus: magnetic resonance imaging and review of the literature. J Rheumatol. 1990 Jan; 17(1):89-92. PMID: 2179553.
      Citations:    
    358. Gahl WA, Dalakas MC, Charnas L, Chen KT, Pezeshkpour GH, Kuwabara T, Davis SL, Chesney RW, Fink J, Hutchison HT. Myopathy and cystine storage in muscles in a patient with nephropathic cystinosis. N Engl J Med. 1988 Dec 1; 319(22):1461-4. PMID: 3185663.
      Citations:    
    359. Willison HJ, Trapp BD, Bacher JD, Dalakas MC, Griffin JW, Quarles RH. Demyelination induced by intraneural injection of human antimyelin-associated glycoprotein antibodies. Muscle Nerve. 1988 Nov; 11(11):1169-76. PMID: 2465494.
      Citations:    
    360. Ilyas AA, Willison HJ, Dalakas MC, Whitaker JN, Quarles RH. Identification and characterization of gangliosides reacting with IgM paraproteins in three patients with neuropathy associated with biclonal gammopathy. J Neurochem. 1988 Sep; 51(3):851-8. PMID: 2457654.
      Citations:    
    361. Hatazawa J, Brooks RA, Dalakas MC, Mansi L, Di Chiro G. Cortical motor-sensory hypometabolism in amyotrophic lateral sclerosis: a PET study. J Comput Assist Tomogr. 1988 Jul-Aug; 12(4):630-6. PMID: 3260610.
      Citations:    
    362. Ilyas AA, Li SC, Chou DK, Li YT, Jungalwala FB, Dalakas MC, Quarles RH. Gangliosides GM2, IV4GalNAcGM1b, and IV4GalNAcGC1a as antigens for monoclonal immunoglobulin M in neuropathy associated with gammopathy. J Biol Chem. 1988 Mar 25; 263(9):4369-73. PMID: 2450092.
      Citations:    
    363. Dalakas MC, Stone G, Elder G, Ceroni M, Madden D, Román G, Sever JL. Tropical spastic paraparesis: clinical, immunological, and virological studies in two patients from Martinique. Ann Neurol. 1988; 23 Suppl:S136-42. PMID: 2894805.
      Citations:    
    364. Madden DL, Mundon FK, Tzan NR, Fuccillo DA, Dalakas MC, Calabrese V, Elizan TS, Sever JL. Serologic studies of MS patients, controls, and patients with other neurologic diseases: antibodies to HTLV-I, II, III. Neurology. 1988 Jan; 38(1):81-4. PMID: 2827054.
      Citations:    
    365. Dalakas MC, Pezeshkpour GH. Neuromuscular diseases associated with human immunodeficiency virus infection. Ann Neurol. 1988; 23 Suppl:S38-48. PMID: 2831801.
      Citations:    
    366. Madden DL, Mundon FK, Tzan NR, Fuccillo DA, Dalakas MC, Calabrese V, Elizan TS, Román GC, Sever JL. Antibody to human and simian retrovirus, HTLV-I, HTLV-II, HIV, STLV-III, and SRV-I not increased in patients with multiple sclerosis. Ann Neurol. 1988; 23 Suppl:S171-3. PMID: 3279901.
      Citations:    
    367. Dalakas MC, Yarchoan R, Spitzer R, Elder G, Sever JL. Treatment of human immunodeficiency virus-related polyneuropathy with 3'-azido-2',3'-dideoxythymidine. Ann Neurol. 1988; 23 Suppl:S92-4. PMID: 3162359.
      Citations:    
    368. Dalakas MC, Pezeshkpour GH, Flaherty M. Progressive nemaline (rod) myopathy associated with HIV infection. N Engl J Med. 1987 Dec 17; 317(25):1602-3. PMID: 3683496.
      Citations:    
    369. Dalakas MC, Hatazawa J, Brooks RA, Di Chiro G. Lowered cerebral glucose utilization in amyotrophic lateral sclerosis. Ann Neurol. 1987 Nov; 22(5):580-6. PMID: 3501273.
      Citations:    
    370. Dalakas MC, Engel WK. Prednisone-responsive limb-girdle syndrome: a special disorder? Neuropediatrics. 1987 May; 18(2):88-90. PMID: 3601003.
      Citations:    
    371. Dalakas MC. New neuromuscular symptoms after old polio ("the post-polio syndrome"): clinical studies and pathogenetic mechanisms. Birth Defects Orig Artic Ser. 1987; 23(4):241-64. PMID: 3040141.
      Citations:    
    372. Ilyas AA, Dalakas MC, Brady RO, Quarles RH. Sulfated glucuronyl glycolipids reacting with anti-myelin-associated glycoprotein monoclonal antibodies including IgM paraproteins in neuropathy: species distribution and partial characterization of epitopes. Brain Res. 1986 Oct 15; 385(1):1-9. PMID: 2429733.
      Citations:    
    373. Dalakas MC. Chronic idiopathic ataxic neuropathy. Ann Neurol. 1986 Jun; 19(6):545-54. PMID: 3014995.
      Citations:    
    374. Dalakas MC, Elder G, Hallett M, Ravits J, Baker M, Papadopoulos N, Albrecht P, Sever J. A long-term follow-up study of patients with post-poliomyelitis neuromuscular symptoms. N Engl J Med. 1986 Apr 10; 314(15):959-63. PMID: 3007983.
      Citations:    
    375. Dalakas MC, Cunningham G. Characterization of amyloid deposits in biopsies of 15 with "sporadic" (non-familial or plasma cell dyscrasia amyloid polyneuropathy. Acta Neuropathol. 1986; 69(1-2):66-72. PMID: 3008491.
      Citations:    
    376. Ilyas AA, Quarles RH, Dalakas MC, Brady RO. Polyneuropathy with monoclonal gammopathy: glycolipids are frequently antigens for IgM paraproteins. Proc Natl Acad Sci U S A. 1985 Oct; 82(19):6697-700. PMID: 2413445.
      Citations:    
    377. Dalakas MC, Fujihara S, Askanas V, Engel WK, Glenner GG. Nature of amyloid deposits in hypernephroma. Immunocytochemical studies in 2 cases associated with amyloid polyneuropathy. Am J Pathol. 1984 Sep; 116(3):447-54. PMID: 6383062.
      Citations:    
    378. Dalakas MC, Teräväinen H, Engel WK. Tremor as a feature of chronic relapsing and dysgammaglobulinemic polyneuropathies. Incidence and management. Arch Neurol. 1984 Jul; 41(7):711-4. PMID: 6743059.
      Citations:    
    379. Dalakas MC, Papadopoulos NM. Paraproteins in the spinal fluid of patients with paraproteinemic polyneuropathies. Ann Neurol. 1984 Jun; 15(6):590-3. PMID: 6430213.
      Citations:    
    380. Ilyas AA, Quarles RH, MacIntosh TD, Dobersen MJ, Trapp BD, Dalakas MC, Brady RO. IgM in a human neuropathy related to paraproteinemia binds to a carbohydrate determinant in the myelin-associated glycoprotein and to a ganglioside. Proc Natl Acad Sci U S A. 1984 Feb; 81(4):1225-9. PMID: 6199795.
      Citations:    
    381. Dalakas MC, Flaum MA, Rick M, Engel WK, Gralnick HR. Treatment of polyneuropathy in Waldenström's macroglobulinemia: role of paraproteinemia and immunologic studies. Neurology. 1983 Nov; 33(11):1406-10. PMID: 6314179.
      Citations:    
    382. Dalakas MC, Engel WK. Treatment of "permanent" muscle weakness in familial Hypokalemic Periodic Paralysis. Muscle Nerve. 1983 Mar-Apr; 6(3):182-6. PMID: 6855804.
      Citations:    
    383. Dalakas MC, Rose JW, Paul J, Engel WK, McClure JE, Goldstein AL. Increased circulation of T lymphocytes bearing surface thymosin alpha 1 in patients with myasthenia gravis: effect of thymectomy. Neurology. 1983 Feb; 33(2):144-9. PMID: 6337347.
      Citations:    
    384. Dalakas MC, Engel WK. Amyloid in hereditary amyloid polyneuropathy is related to prealbumin. Arch Neurol. 1981 Jul; 38(7):420-2. PMID: 7018469.
      Citations:    
    385. Dalakas MC, Engel WK. Polyneuropathy with monoclonal gammopathy: studies of 11 patients. Ann Neurol. 1981 Jul; 10(1):45-52. PMID: 6267981.
      Citations:    
    386. Dalakas MC, Engel WK, McClure JE, Goldstein AL, Askanas V. Immunocytochemical localization of thymosin-alpha 1 in thymic epithelial cells of normal and myasthenia gravis patients and in thymic cultures. J Neurol Sci. 1981 May; 50(2):239-47. PMID: 7014787.
      Citations:    
    387. Dalakas MC, Engel WK, McClure JE, Goldstein AL, Askanas V. Identification of human thymic epithelial cells with antibodies to thymosin alpha 1 in myasthenia gravis. Ann N Y Acad Sci. 1981; 377:477-85. PMID: 7041758.
      Citations:    
    388. Engel WK, Lichter AS, Dalakas MC. Splenic and total-body irradiation treatment of myasthenia gravis. Ann N Y Acad Sci. 1981; 377:744-54. PMID: 7041759.
      Citations:    
    389. Dalakas MC, Engel WK. Chronic relapsing (dysimmune) polyneuropathy: pathogenesis and treatment. Ann Neurol. 1981; 9 Suppl:134-45. PMID: 7224612.
      Citations:    
    390. Dalakas MC, Engel WK. Immunoglobulin and complement deposits in nerves of patients with chronic relapsing polyneuropathy. Arch Neurol. 1980 Oct; 37(10):637-40. PMID: 6252877.
      Citations:    
    391. Dalakas MC, Houff SA, Engel WK, Madden DL, Sever JL. CSF "monoclonal" bands in chronic relapsing polyneuropathy. Neurology. 1980 Aug; 30(8):864-7. PMID: 6251407.
      Citations:    
    392. Askanas V, Engel WK, Dalakas MC, Lawrence JV, Carter LS. Human schwann cells in tissue culture: histochemical and ultrastructural studies. Arch Neurol. 1980 Jun; 37(6):329-37. PMID: 6248001.
      Citations:    
    393. Dalakas MC, Engel WK, McClure JE, Goldstein AL. Thymosin alpha 1 in myasthenia gravis. N Engl J Med. 1980 May 8; 302(19):1092-3. PMID: 7366630.
      Citations:    
    394. Dalakas MC, Engel WK. Role of immunoglobulin light chains in the pathogenesis of amyloid polyneuropathy associated with occult plasma-cell dyscrasia. Trans Am Neurol Assoc. 1979; 104:227-9. PMID: 233329.
      Citations:    
    Dalakas's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (858)
    Explore
    _
    Co-Authors (3)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _